Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
METHODS AND APPARATUS FOR DELIVERY OF NONINVASIVE ULTRASOUND BRAIN THERAPY THROUGH INTACT SKULL
Document Type and Number:
WIPO Patent Application WO/1998/007373
Kind Code:
A1
Abstract:
Methods and apparatus for delivery of ultrasound to the brain, without requiring removal of portions of the skull, call for transmission of ultrasound with a plurality of transducers (12) aimed to induce cavitation at least at a selected region of the brain. An excitation source (22) is arranged for driving at least selected transducers at differing phases with respect to one another, e.g., to compensate for phase shifts (or phase distortions) effected by the skull on the ultrasound output by each transducer. As a result, the ultrasound waves reaching the selected region from the transducers arrive substantially in phase with one another, e.g., within 90 degrees and preferably 45 degrees, and still more preferably 20 degrees of one another.

Inventors:
HYNYNEN KULLERVO (US)
Application Number:
PCT/US1997/014760
Publication Date:
February 26, 1998
Filing Date:
August 21, 1997
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
BRIGHAM & WOMENS HOSPITAL (US)
HYNYNEN KULLERVO (US)
International Classes:
A61B17/22; A61N7/00; A61B8/00; A61B8/08; A61B19/00; (IPC1-7): A61B17/00
Foreign References:
US5158071A1992-10-27
US5524625A1996-06-11
US5665054A1997-09-09
US5316000A1994-05-31
US5643179A1997-07-01
US5431621A1995-07-11
US5656015A1997-08-12
US5590657A1997-01-07
Attorney, Agent or Firm:
Powsner, David J. (Hall & Stewart Exchange Place, 53 State Stree, Boston MA, US)
Download PDF:
Claims:
CLAIMS:
1. An apparatus for delivering ultrasound through the skull to the brain of a patient, the apparatus comprising A. a plurality of transducers, B. an excitation source for driving the plurality of transducers to generate and transmit ultrasound through the skull to induce cavitation at least at a selected region of the brain, C. the excitation source driving at least selected transducers at differing phases with respect to one another.
2. An apparatus according to claim 1, wherein A. the excitation source drives each of the selected transducers at a phase that compensates for a phase shift effected by the skull in the ultrasound generated and transmitted to the selected region by that transducer, B. so that the ultrasound generated by the selected transducers arrive substantially in phase with one another at the selected region.
3. An apparatus according to claim 2, wherein the excitation source drives each of the selected transducers at a phase so that the ultrasound generated by the selected transducers arrive at phases within 90° of one another at the selected region.
4. An apparatus according to claim 2, wherein the excitation source drives each of the selected transducers at a phase so that the ultrasound generated by the selected transducers arrive at phases within 45° of one another at the selected region.
5. An apparatus according to claim 2, wherein the excitation source drives each of the selected transducers at a phase so that the ultrasound generated by the selected transducers arrive at phases within 20° of one another at the selected region.
6. An apparatus according to claim 1, wherein the excitation source drives the plurality of transducers to deliver ultrasound to the selected region at a frequency ranging from 0.01 MHz to 10 MHz 7. An apparatus according to claim 6, wherein the excitation source drives the plurality of transducers to deliver ultrasound to the selected region at a frequency ranging from 0.1 MHz to 2 MHz 8. An apparatus according to claim 6, wherein the excitation source drives the plurality of transducers to deliver ultrasound to the selected region at a sonication duration ranging from 100 nanoseconds to 30 minutes.
7. 9 An apparatus according to claim 8, wherein the excitation source drives the plurality of transducers to deliver ultrasound to the selected region with continuous wave operation.
8. 10 An apparatus according to claim 9, wherein the excitation source drives the plurality of transducers to deliver ultrasound to the selected region with burst mode operation, where burst mode repetition varies from 0.01 Hz to 1 MHz 11. An apparatus for delivering ultrasound through the skull to the brain of a patient, the apparatus comprising A. an ultrasound transducer, B.
9. an excitation source for driving the transducer to generate and transmit ultrasound through the skull to induce cavitation at least at a selected region of the brain.
10. An apparatus according to claim 11, wherein the excitation source drives the transducer to deliver ultrasound to the selected region at a frequency ranging from 20 kHz to 10 MHz.
11. An apparatus according to claim 6, wherein the excitation source drives the plurality of transducers to deliver ultrasound to the selected region at a frequency ranging from 0.02 MHz to 10 MHz.
12. An apparatus according to claim 13, wherein the excitation source drives the plurality of transducers to deliver ultrasound to the selected region at a sonication duration ranging from 100 nanoseconds to 30 minutes.
13. An apparatus according to claim 13, wherein the excitation source drives the plurality of transducers to deliver ultrasound to the selected region with continuous wave operation.
14. An apparatus according to claim 15, wherein the excitation source drives the plurality of transducers to deliver ultrasound to the selected region with burst mode operation, where burst mode repetition varies from 0.01 Hz to 1 MHz 17. A method for delivering ultrasound through the skull to the brain of a patient, the apparatus comprising the steps of A. placing a plurality of transducers in the vicinity of an exterior surface of the patient's skull, B. driving the plurality of transducers to generate and transmit ultrasound through the skull to induce cavitation at least at a selected region of the brain, C.
15. the driving step including driving at least selected transducers at differing phases with respect to one another.
16. A method according to claim 17, wherein step (C) includes driving each of the selected transducers at a phase that compensates for a phase shift effected by the skull in the ultrasound generated and transmitted to the selected region by that transducer, such that the ultrasound generated by the selected transducers arrive substantially in phase with one another at the selected region.
17. A method according to claim 18, wherein step (C) includes driving each of the selected transducers at a phase so that the ultrasound generated by the selected transducers arrive at phases within 90° of one another at the selected region.
18. A method according to claim 18, wherein step (C) includes driving each of the selected transducers at a phase so that the ultrasound generated by the selected transducers arrive at phases within 45° of one another at the selected region.
19. A method according to claim 18, wherein step (C) includes driving each of the selected transducers at a phase so that the ultrasound generated by the selected transducers arrive at phases within 20° of one another at the selected region.
20. A method according to claim 17, wherein step (B) includes driving the plurality of transducers to deliver ultrasound to the selected region at a frequency ranging from 0.02 MHz to 10 MHz 23. A method according to claim 17, wherein step (B) includes driving the plurality of transducers to deliver ultrasound to the selected region at a frequency ranging from 0.1 MHz to 2 MHz 24. A method according to claim 17, wherein step (B) includes driving the plurality of transducers to deliver ultrasound to the selected region at a sonication duration ranging from 100 nanoseconds to 30 minutes.
21. 25 A method according to claim 17, wherein step (B) includes driving the plurality of transducers to deliver ultrasound to the selected region with continuous wave operation.
22. 26 A method according to claim 17, wherein step (B) includes driving the plurality of transducers to deliver ultrasound to the selected region with burst mode operation, where burst mode repetition varies from 0.01 Hz to 1 MHz 27. A method for delivering ultrasound through the skull to the brain of a patient, the apparatus comprising A. placing an ultrasound transducer in a vicinity of an exterior surface of the patient's skull, B.
23. driving the transducer to generate and transmit ultrasound through the skull to induce cavitation at least at a selected region of the brain.
24. A method claim 27, wherein step (B) includes driving the transducer to deliver ultrasound to the selected region at a frequency ranging from 0.02 MHz to 10 MHz 29. A method according to claim 28, wherein step (B) includes driving the plurality of transducers to deliver ultrasound to the selected region at a frequency ranging from 0.1 MHz to 2 MHz 30. A method according to claim 29, wherein step (B) includes driving the plurality of transducers to deliver ultrasound to the selected region at a sonication duration ranging from 100 nanoseconds to 30 minutes.
25. 31 A method according to claim 30, wherein step (B) includes driving the plurality of transducers to deliver ultrasound to the selected region with continuous wave operation.
26. 32 A method according to claim 31, wherein step (B) includes driving the plurality of transducers to deliver ultrasound to the selected region with burst mode operation, where burst mode repetition varies from 0.01 Hz to 1 MHz 33. An apparatus for delivering ultrasound through the skull to the brain of a patient, the apparatus comprising A. a plurality of transducers arranged in a twodimensional array, and B.
27. an excitation source for driving the plurality of transducers to generate and transmit ultrasound through the skull to induce cavitation at least at a selected region of the brain.
28. An apparatus according to claim 33, wherein the plurality of transducers are arranged in an array having any of a substantially circular and a substantially annular crosssection.
29. An apparatus according to claim 34, wherein the plurality of transducers are arranged in an array having a substantially circular crosssection.
30. An apparatus according to claim 34, wherein the plurality of transducers are at least one of (i) mounted in, and (ii) separated from one another by, a damping agent.
31. An apparatus according to claim 36, wherein the damping agent is any of a natural or synthetic rubber.
32. An apparatus according to claim 34, wherein the excitation source drives at least selected transducers at differing phases with respect to one another.
33. An apparatus according to claim 1, wherein excitation source drives each of the selected transducers at a phase that compensates for a phase shift effected by the skull in the ultrasound generated and transmitted to the selected region by that transducer, so that the ultrasound generated by the selected transducers arrive substantially in phase with one another at the selected region.
34. A method for delivering ultrasound through the skull to the brain of a patient, the apparatus comprising the steps of A. placing a plurality of transducers in the vicinity of an exterior surface of the patient's skull, B. driving each of at least selected transducers generate and transmit ultrasound through the skull, and determining a phase shift effected by the skull in ultrasound generated and transmitted by each such transducer, C. driving the plurality of transducers, together, to generate and transmit ultrasound through the skull to induce cavitation at least at a selected region of the brain, D.
35. the driving step including driving at least selected the transducers at phases determined in accord with step (B) so that the ultrasound generated by at least the selected transducers arrive substantially in phase with one another at the selected region.
36. A method according to claim 40, wherein the selected region ranges from 1 mm31 cm3 in volume.
Description:
Methods and Apparatus for Delivery of Noninvasive Ultrasound Brain Therapy Through Intact Skull Sponsorship The research resulted, at least, in part, from work performed under NCI Research Grant No 46627.

Reference to Related Applications This application claims the benefit of the filing date of and is a continuation- in-part of copending, commonly assigned United States Patent Application Serial No.

08/711,289, filed August 21,1996 (Attorney Docket No. 0092664-0008), the teachings of which are incorporated herein by reference. This application also claims the benefit of the filing date of copending United States Provisional Application Serial Nos. 60/034,084 (filed 12/23/96), and 60/045,453 (filed 5/1/97). The teachings of those provisional applications are incorporated herein by reference.

Background of Invention The invention pertains to medical systems and, more particularly, to methods and apparatus for non-invasive application of focused ultrasound to the brain. The invention can be used, for example, in the diagnosis and treatment of neural ailments.

According to the prior art, treatment of tissues lying at specific locations within the skull are limited to removal or ablation. While these treatments have proven effective for certain localized disorders, such as tumors, they involve delicate, time-consuming procedures that may result in destruction of otherwise healthy tissues. The treatments are generally not appropriate for disorders in which diseased tissue is integrated into healthy tissue, except in instances where destruction of the latter will not unduly effect neurologic function.

The noninvasive nature of ultrasound surgery has special appeal in the brain where it is often desirable to destroy or treat deep tissue volumes without disturbing the healthy tissues. Focussed ultrasound beams have been used for noninvasive surgery in many other parts of the body. Ultrasound penetrates well through soft tissues and, due to the short wavelengths (1.5 mm at 1 MHz), it can be focused to

spots with dimensions of a few millimeters. By heating tumorous or cancerous tissue in the abdomen, for example, it is possible to ablate the diseased portions without significant damage to surrounding healthy tissue.

Notwithstanding the potential benefits of ultrasound diagnostics and therapy of the brain, it has been commonly accepted that ultrasound cannot be applied through the intact skull. Early experiments, for example, showed that ultrasound is strongly attenuated by bone, and that brain tissue damage close to the skull results from the high temperatures caused by the energy loss. Accordingly, all of the ultrasound brain treatments performed so far have required the skull bone to be removed prior to the sonication. This makes the procedure invasive, and expensive with an added risk of complications.

The requirement of surgical removal of the skull has been the main obstacle that has prevented ultrasound therapy to be widely tested in the brain despite the possibility of its clear benefits compared to other techniques. Accordingly, an object of this invention is to provide improved medical methods and apparatus, for diagnosis and therapy of the brain. A more particular object of the invention is to provide improved methods and apparatus for application of ultrasound to the brain.

A more particular object of the invention is to provide such methods and apparatus as do not require removal of portions of the skull, via craniectomy or other such procedures.

Still another object of the invention is to provide such methods and apparatus as can be used to precisely target regions within the brain.

Still yet another object of the invention is to provide such methods and apparatus as can be used to effect heating or other physiologic change at such precisely targeted regions, without effecting substantial change in the surrounding, or other, regions of the brain or skull.

Another object of the invention is to provide such methods and apparatus as can be utilized over a wide range of ultrasonic frequencies.

Still another object of the invention is to provide such methods and apparatus as can be implemented utilizing conventional materials.

Yet still another object of the invention is to provide such methods as can be implemented without excessive expense.

Summary of the Invention The foregoing and other objects are met by the invention, which provides in one aspect methods and apparatus for delivery of cavitating ultrasound to the brain, without requiring removal of portions of the skull.

Thus, in one aspect, the invention provides an apparatus for delivering ultrasound, through intact skull, to the brain comprising a plurality of transducers and an excitation source for driving each to induce cavitation at least at a selected region of the brain. The excitation source is particularly arranged for driving at least selected transducers at differing phases with respect to one another, e. g., to compensate for phase shifts (or phase distortions) effected by the skull on the ultrasound output by each transducer. As a result, the ultrasound waves reaching the selected region from the transducers arrive substantially in phase with one another, e. g., within 90° and, preferably, within 45"and, still more preferably, within 20° of one another.

The excitation source drives the transducers to deliver ultrasound to the selected region at a frequency ranging from 0.01 MHz to 10 MHz and, preferably, from 0.1 MHz to 2 MHz. Sonication duration for the ultrasound ranges, according to further aspects of the invention, from 100 nanoseconds to 30 minutes. According to still further aspects, the invention provides for delivery of ultrasound to the selected region with continuous wave operation or burst mode operation, where burst mode repetition varies from 0.01 Hz to 1 MHz

Further aspects of the invention provide an apparatus as described above, in which only a single transducer is used.

Still further aspects of the invention provide methods for operating transducer arrays as described above.

These and other aspects of the invention are evident in the drawings and in the text that follows.

Brief Description of the Drawings A further understanding of the invention may be attained by reference to the drawings, in which: Figure I depicts an embodiment of the invention and an experimental setup for testing it.

Figure 2 depicts an embodiment of the invention for application of ultrasound to the brain of an animal.

Figure 3 depicts a phased array for application of ultrasound to the brain in accord with one practice of the invention.

Figures 4A-4H illustrate the ultrasound pressure amplitude distribution in water across the focus of a transducer according to the invention at various frequencies, with and without skull sections in front of the transducer.

Figures 5A and 5B illustrate the effect of applying ultrasound in accordance with the invention to brain tissue.

Figures 6A and 6B illustrate phase errors measured at the focus of ultrasound transducer arrays with a piece of skull in front of the transducers.

Figures 7A-7C illustrate the pressure amplitude profiles across the focus of an ultrasound transducer phased array in water, through the bone, and through the bone with phase correction.

Figure 8 illustrates the pressure amplitude distribution along the central axis of an ultrasound transducer array without and with the phase correction.

Figures 9A-9C illustrate the ultrasound pressure amplitude distribution measured across the focus of an ultrasound phased array in water, through skull without phase correction, and through skull with phase correction.

Figure 10 depicts an embodiment of the invention for delivery of cavitating ultrasound to a patient's brain through the skull using a multi-element transducer array.

Figure 11 depicts a method for delivery of cavitating ultrasound to a patient's brain through the skull using a transducer array.

Detailed Description of the Illustrated Embodiment Discussed below are methods and apparatus according to the invention for noninvasive delivery of ultrasound through intact skull to the brain. These permit ultrasound propagation through skull to effect cavitation, without causing undesired heating of the brain or, more generally, central nervous system (CNS) tissues. These also deliver adequate ultrasound power to ablate tissues, or to otherwise induce changes, at focal points (or regions) within the brain. As used herein,"tissue"refers to fluids, tissues or other components on or within a patient's body.

Figure 10 depicts an apparatus according to the invention for delivery of ultrasound to the brain. The apparatus 10 includes an array of transducers 12 disposed on or near the external surface of the head of a human patient. The array 12 can constitute a single transducer, e. g., a spherically curved piezoelectric bowl of the

type described below, though preferably, array 12 comprises a plurality of transducers arranged in a one-, two-or three-dimensional configuration.

Referring to Figure 3, for example, in one embodiment of the invention, array 12 comprises 60 individual piezoelectric ceramic transducers mounted in a bowl of circular cross-section. The transducer elements, which can be, for example, 1 cm2 piezoelectric ceramic pieces, are mounted in silicone rubber or any other material suitable damping agent for minimizing the mechanical coupling therebetween.

Transducer arrays of this type are known in the art, as described, for example in Fan et al,"Control of the Necrosed Tissue Volume During Noninvasive Ultrasound Surgery Using a 16-Element Phased Array,"Medical Physics, v. 22, pp. 297 et seq (1995), the teachings of which (e. g., at Figure 1 and the accompanying text) are incorporated herein by reference. The construction of a spherically curved phased array comprising multiple square-element transducers is shown in Figure 1 and the accompanying text of that publication.

In the illustrated embodiment, each transducer of array 12 is independently driven by power and the control elements 18-22 to generate ultrasound for transmission through the patient's skull into the CNS tissues. More particularly, the transducers in array 12 are individually coupled, via coaxial cables 16, to separate channels of a driving system 18. Each channel of that system 18 includes an amplifier and a phase shifter, as shown. A common radio frequency (RF) signal is driven to each channel by radio frequency generator 22. Together, the radio frequency generator 22 and driving system 18 drive the individual transducers of array 12 at the same frequency, but at different phases, so as to transmit a focused ultrasound beam through the patient's skull to a selected region within the brain.

Unlike prior art systems, there is no need to remove portions of the skull beneath the array 12, e. g., via craniectomy or other such surgical procedure.

The radio frequency generator 22 can be of any commercially available type.

A preferred such generator is available from Stanford Research Systems, Model

DS345. The generator is operated in a conventional way so as to generate an excitation signal, which is amplified and phase-shifted by the individual channels of driving system 18, in order to induce the corresponding transducers of array 12 to radiate ultrasound (e. g., in the range 0.01 MHz to 10 MHz).

As illustrated, each channel in the driving system 18 includes a radio frequency amplifier. These can be any RF amplifiers of the type commercially available in the art.

The phase shifting component of each channel of driving system 18 is constructed and operated in the conventional manner known in the art. Particularly, each phase shifter shifts the phase of an incoming RF excitation signal, received from RF generator 22, by an amount al, a2, a3, etc., as shown in the drawing. These phase shift factors al, a2, a3, etc., can be pre-stored in the channels of driving system 18 or, preferably, generated by a controller 20. That controller 20 can be a general purpose, or special purpose, digital data processor programmed in a conventional manner in order to generate and apply phase shift factors in accord with the teachings hereof.

The phase shift factors, al, a2, a3, etc. serve two purposes. The first is to steer the composite ultrasound beam generated by transducer array 12 so that it is focused on a desired region within the patient's brain. The component of each phase shift factor associated with steering is computed in the manner known in the art for steering phased arrays. See, for example, Buchanan et al,"Intracavitary Ultrasound Phased Array System,"IEEE Transactions Biomedical Engineering, v. 41, pp. 1178- 1187, the teachings of which are incorporated herein by reference. Array steering, or focusing, is particularly discussed in that article, for example, at pages 1179-1181 and, more particularly, in the section entitled"Focusing Techniques,"the teachings of which are incorporated herein by reference.

The second component of each phase shift factor al, a2, a3, etc., compensates for phase distortion effected by the skull in the ultrasound ouput by each transducer.

In other words, the second component of the phase shift factors compensates for perturbations and distortions introduced by the skull, the skin/skull interface, the dura matter/skull interface, and by variations in the skull thickness. As those skilled in the art will appreciate, the two components that make up the phase shift factor for each channel of the driving system 18 are summed in order to determine the composite phase shift factor for the respective channel.

The phase corrections that constitute the aforementioned second component of each phase shift factor can be determined a number of ways. In one embodiment of the invention, that component is determined from measurements of the thickness of the patient's skull under each transducer in array 12. Such skull thickness measurements can be made using conventional imaging techniques, such as computed tomography (CT) or magnetic resonance imaging (MRI).

In an alternative embodiment, the aforementioned second component of each phase shift factor is determined by placing the array 12 on the patient's head and exciting individual transducers with a short ultrasound pulse. The echo back from the inner surfaces of the skull are monitored by the transducer array 12. The effect of the skull on ultrasound generated by each transducer is determined from those echos in accord with conventionally known relations.

In still further alternative embodiments, the aforementioned second component of each phase shift factor is determined by implanting small hydrophones in the patient's brain. These are used to monitor the phase of the ultrasound generated by each transducer, e. g., in a manner similar to that described below in connection with Figure 1.

In lieu of illustrated components 18-22, the transducer array 12 can be driven by a driving system of the type disclosed in Buchanan et al, supra e. g. at Figure 2 thereof, the teachings of which are incorporated herein by reference. Such a driving system would, of course, require modification in accord with the teachings hereof in

order to incorporate phase shift factors al a2, a3, etc., having first and second components as described herein and above.

Referring to Figure 11, the system 10 is operated as described below in order to deliver ultrasound through the patient's skull to induce cavitation at a desired region of the brain.

In step 24, the transducer array 24 is positioned on the patient's head. This is preferably accomplished in the conventional manner known in the art for insuring ultrasound transmission to the brain. The array is typically positioned over, and as close to, the region in which cavitation is to be induced. However, where intervening or adjacent cranial or CNS tissues might be adversely affected, the array can be positioned elsewhere and focused accordingly.

In step 26, the aforementioned second component of the phase shift factor for each transducer is determined. This is accomplished in the manner described above, e. g., by individual exciting each element of the array and measuring the echo back.

The alternative mechanisms described above can also be used to determine those components. Those skilled in the art will appreciate that in instances where the alternative mechanisms are used, they need not be performed after the array is positioned but, can be performed at some other prior time.

In step 28, the remaining components of each transducers'phase shift factor are determined. Particularly, those components associated with steering the array for delivery of ultrasound to the desired region are determined. Such determination is made, as indicated above, in the conventional manner known in the art for steering phased arrays.

In step 30, the array is excited, e. g., by control and driving elements 18-22, to focus ultrasound in the patient's head. As noted throughout, because the invention provides correction for phased distortion induced by the skull, that ultrasound can be supplied directly through the skull without the need for removal of a piece thereof.

The ultrasound is applied in doses and timing sufficient to induce cavitation in the desired region, which may be, e. g., from 1 mm3-1 cm3, or larger. Those skilled in the art will appreciate that ultrasound waves in the frequency range of 0.01 MHz to 10 MHz and, preferably, from 0.10 MHz to 2 MHz can be applied with sonication duration ranging from 100 nanoseconds to 30 minutes, with continuous wave or burst mode operation. The burst mode repetition varies from 0.01 Hz to 1 MHz In embodiments where the transducer array 12 includes only a single transducer, e. g., a 10 cm diameter piezoelectric ceramic element as described elsewhere herein, step 26 is not utilized. In such an embodiment, the"array"is aimed based on its focal point. This is determined as a function of the size, radius of curvature and frequency output of the transducer in the manner known in the art. In a preferred embodiment, these factors are adjusted so that the transducer can be placed directly on the patient's skull, as above. However, where minor corrections are necessary, the transducer can be spaced apart from the skull, as necessary, in order to insure proper positioning of the focal point.

Theory When an ultrasound beam propagates to a deep target location in the brain part of the energy is reflected back at the skin-skull interface due to the high acoustic mismatch between these two tissues. The propagating wave in the skull suffers attenuation losses due to scattering and absorption. The acoustic mismatch at the bone-dura interface causes part of the remaining wave to reflect back to the skull.

The total insertion loss through skull depends on the frequency, and can be, on average, about 10 dB, and 20 dB at 0.5, and 1.5 MHz, respectively. The wave is further attenuated by absorption (about 5 Np/m/MHz) while it travels through the brain to the target volume.

An ultrasound beam delivered to the brain can effect change in CNS tissues and fluids (herein, simply"tissue"or"brain tissue,"etc.) by two mechanisms : heating and cavitation. The ultrasound beam can heat the tissue temperature due to energy absorption from the wave resulting in different degrees of thermal damage to the

tissue depending on the temperature reached. For exposures of a few seconds, temperatures of above about 60° C are adequate to coagulate proteins and thus, necrose the tissue. The induced temperature elevation during short ultrasound exposures depends mainly on the absorbed power (<q>) although the shape and size of the focal spot can have a significant impact due to thermal conduction. The rate of temperature rise (dT/dt) at the very beginning of an ultrasound pulse can be calculated from the pressure amplitude of the field (P), as follows: dT/dt = <q>/p c, where <q> = a P2/pV [2] p is the density (ph = 1030 kg/m', ps = 1380-1810 kg/m') (s= skull, b = brain), c is the specific heat of the medium (Cb =3. 9 kJ/kg/°C ; c, =2.1-2.7 kJ/kg/oC), v is the speed of sound, and a is the amplitude absorption coefficient of the tissue (a,, = 5Np/m/MHz, as = 50 Np/m at 0.5 MHz, aS = 300 Np/m at 1.5 MHz (if all attenuated energy is assumed to be absorbed)).

In order to achieve the same temperature within the target volume as in the skull, the ultrasound beam has to be focused to overcome the difference in the acoustic properties. The square of the pressure amplitude (PI) is directly proportional to the ultrasound beam area allowing the required area gain (AG) to be calculated from Equations [1] and [2] by making the rates of temperature rise equal in the skull and the brain: AG = (Pbz/P52) = (aval) (pJpF) (vb/vF) (c,/cs) 30 at 0.5 MHz [3] 60 at1.5 MHz

In addition the area gain has to compensate for the energy loss due to the skull and attenuation in the brain between the skull and the focal point: AG'= (a. e-')-'= 13 at 0.5 MHz [4] 250 at 1.5 MHz where, ai is the insertion loss of skull, P is the amplitude attenuation coefficient, f is the frequency and x is the depth in the brain.

The total area gain is the product of these two area gains and is approximately 400 and 15000 at 0.5 MHz and 1.5 MHz, respectively when the focus is located at the depth of 6 cm in the brain. These calculations are first order estimates and do not take into account phase shifts introduced by the variable thickness of the bone or thermal conduction and perfusion effects.

The second mechanism, cavitation requires negative pressure amplitudes that are large enough to form gas bubbles in the tissue. The pressure wave causes the bubbles to expand and then collapse. The collapse of the bubbles causes high temperatures and pressures that can cause direct mechanical damage to the tissue.

Cavitation can offer more therapeutic options than thermal exposures of brain. The cavitation threshold in the soft tissues and in bone appears to be similar.

Thus, focusing a cavitation-inducing ultrasound beam overcomes the attenuation losses in the bone and brain, but need not overcome differences in absorption coefficients, as is the case with the heat-inducing exposures. The beam area of cavitation-inducing ultrasound propagating through the skull has to be about 13 and 250 times larger than the focal area at frequencies of 0.5 and 1.5 MHz, respectively. These area gains are 30 and 60 times smaller than the gains required for induction of thermal effects. The cavitation is not influenced by thermal conduction or perfusion effects. Therefore, it is clear that cavitation has significant advantages

over the thermal effects. This is particularly true in instances where the ultrasound energy must be delivered to small focal regions that require high frequencies.

Cavitation requires high pressure amplitudes but only short exposure durations, therefore cavitational effects can be induced without significant temperature elevation. For CNS tissues, sonications with durations of only 1 ms are adequate for bubble formation. The required peak intensities at 0.936 MHz during these sonications are measured to be around 4000 Wcm-2 and 2000 Wcm-2at 1 ms and 1 s exposures, respectively. Using these intensity values and the average ultrasound attenuation in brain of 5 Np/m and in bone 120 Np/m at 1 MHz, the maximum peak temperature elevation in the brain can be estimated (from equations 1 and 2) to be about 60° C and 0.1 ° C during the 1 s and 1 ms exposures, respectively. The corresponding temperature elevations in bone, if the focus was in the bone, are 1800° C and 3.6° C. During the sonications the temperature elevation in the bone would be reduced proportionally with the area gain. These values are frequency dependent. For example, bone heating would be about 13° C for 1 ms pulse at 1.5 MHz. This short thermal exposure is below the threshold for tissue damage. Thermal exposures can be further reduced using multiple pulses that can be repeated at a low frequency (for example 0.1 Hz) thus, eliminating a temperature build up.

Examples In one exemplary embodiment of the invention, which is illustrated in Figure 1, ultrasound was generated using a one-element transducer array having a spherically curved 10 cm diameter piezoelectric ceramic (PZT4) bowl mounted in a plastic holder using silicon rubber. The ceramic had silver or gold electrodes both on the front and back surface. The electrodes were attached to a coaxial cable that was connected to a LC matching network that matched the electrical impedance of the transducer and the cable to the RF amplifier output impedance of 50 ohm and zero phase. The matching. circuit was connected to an RF-amplifier (both ENI A240L and A500 were used in the tests). The RF signal was generated by a signal generator (Stanford Research Systems, Model DS345).

The ultrasound pressure wave distributions were measured using needle hydrophones (spot diameter 0.5 and 1 mm) and an amplifier (Precision Acoustics Ltd). The amplified signal was measured and stored by a oscilloscope (Tektronix, model 2431L). The hydrophone was moved by stepper motors in three dimensions under computer control. The pressure amplitudes measured by the oscilloscope were stored by the computer for each location.

A piece of human skull (top part of the head: front to back 18 cm and maximum width 12 cm) was obtained and fixed in formaldehyde. The acoustic properties of formaldehyde fixed skull and a fresh skull are almost identical. The ultrasound transducer under test was positioned in a water tank the walls and bottom of which were covered by rubber mats to reduce ultrasound reflections. The tank was filled with degassed deionized water. The hydrophone was connected to the scanning frame, and positioned at the focus of the ultrasound field.

Utilizing the setup shown in Figure 1, the embodiment was tested at four different ultrasound frequencies: 0.246 MHz, 0.559 MHz, 1 MHz, and 1.68 MHz The maximum peak pressure amplitudes achievable through the skull at the focus of the transducer was measured at each frequency. A shock wave hydrophone (Sonic

Technologies Inc,) was positioned at the acoustic focus. Bursts of 10-20 cycles were used to separate the acoustic signal from the electrical interference that was picked up by the hydrophone during sonication. Results of the testing are shown in Figures 4A- 4H.

Particularly, Figure 4A illustrates the ultrasound pressure amplitude distribution in water at the focal point of the single transducer driven at 0.246 MHz, without the skull section in place. Figure 4B illustrates this same distribution when the skull was positioned in front of the transducer as illustrated in Figure 1. Figures 4C and 4D illustrate the same distributions (i. e., with and without the skull section in place) for a frequency of 0.559 MHz. Figures 4E and 4F illustrate the same distributions for a frequency of 1 MHz. Figures 4G and 4H illustrate the same distributions for a frequency of 1.68 MHz To demonstrate that the single-element array of this embodiment delivers sufficient energy to induce tissue damage through the skull, in vivo rabbit experiments were performed. In these experiments a window of about 1 Sxl S mm was created in the top of the skull. The skin was placed over the skull opening and the animal was allowed to recover. A minimum of two weeks after the surgery the animal was anesthetized again and placed on top of a sonication tank as illustrated in figure 2 and the 0.556 MHz transducer was aimed such than the focus was located at 10-15 mm in the brain. The skull piece was positioned in between the traducer and the animal. A thermocouple probe (0.05 mm constantan and copper wires were soldered together at the tip) was placed on the skull bone (on the side of the transducer that is expected to be the hottest location) under a thin layer of connective tissue that was still attached on the skull. Then 10 sonications at the maximum power level for the duration of 0.2 s were repeated with the rate of 1 Hz. The animal position was moved and the sonication repeated four times in the same location with a delay of about 5 min between the sonications to allow the bone temperature to return to the baseline. During the 10 s of pulsed sonication the bone temperature increased from the baseline of about 30° C to maximum of 43° C with rapid decay. After the

sonications the rabbit was taken to a MRI scanner and T 1, T2 and contrast enhanced scan were performed. After the imaging the animal sacrificed.

Figure 5A is a scan of the rabbit brain illustrating the effect of 10 sonications for the duration of 0.2 seconds, with a pressure amplitude of 8 MPa, repeated at a rate of 1. Hz. During the 10 seconds of pulse sonication, the bone temperature in the rabbit skull peaked from a baseline of about 30° C to a maximum of 43° C, with rapid decay. The Figure is a T2-weighted fast spin echo image across the brain. The arrow in the Figure shows tissue damage at the focal point of the transducer. The skull window on the top of the head is facing down and, thus, the ultrasound beam propagated from bottom up. Figure 4B is identical to Figure 4A, except insofar as it shows the results where the above sonication was repeated four times.

Further embodiments of the invention utilize multi-element phase arrays of the types illustrated in Figures 3 and 10, in lieu of a single transducer. By controlling the phase of the ultrasound wave as a function of transducer location, these embodiments eliminate the phase distortion caused by the skull and thus, allow accurate aiming and use of higher frequencies, thus, permitting application of ultrasound to induce cavitation through the intact skull in regions of 1 mm to 1 cm3.

Two phased arrays comprising these further embodiments had similar structure and the same driving hardware; the resonant frequency being their only significant difference. The two arrays operated at 0.6 MHz and 1.58 MHz. The radius of curvature of both of the transducers was 10 cm and both of them were cut into approximately 1 cm2 square elements, as shown in Figure 3. The total number of elements in both arrays was 64 although only 60 were driven in the experiments due to hardware limitations. The ceramic bowl was cut using a diamond wire saw so that the elements were completely separated by a 0.3-0.5 mm kerf. The kerf was filled with silicone rubber that kept the array elements together and isolated them acoustically. The silicone rubber allowed the transducer elements to vibrate with minimum amount of clamping. Each transducer element was connected to a coaxial cable and a matching circuit that was individually tuned. The arrays were similar to

the one described in Fan et al, supra, at Figure 1 and the accompanying text, the teachings of which are incorporated herein by reference. The array was driven by an in-house manufactured 64 channel driving system that included an RF amplifier and phase shifter for each channel. The phase and amplitude of the driving signal of each channel was under computer control, as described in Buchanan et al, supra, e. g., at Figure 2 and the accompanying text, the teachings of which are incorporated herein by reference.

In addition to phased arrays configured as described herein and shown in the accompanying drawings, phased arrays can also be constructed in accord with the arrangements described and shown in co-pending, commonly assigned patent application 08/747,033, filed November 8,1996, the teachings of which are incorporated herein by reference.

Using the methodologies and apparatus described above, it is possible to produce a sharp focus through the skull with the single element transducer when the operation frequency was 1 MHz or less. The beams had secondary peaks introduced by the skull but the main peak was the largest. The location of the peak was shifted by the skull by 1-3 mm from the geometric focus, as shown in Figures 4A-4H.

However, the focus was completely obliterated with an operating frequency of 1.67 MHz, as shown in Figure 4H.

The maximum pressure amplitudes achieved at the maximum power output of the amplifier were frequency dependent and are given in the table below. The maximum average pressure amplitude at the frequency of 0.554 MHz was 8.0+/- 0.6 MPa.

AveragePressure P+ P- Frequency(MHzI Amplitude (MPaI MPa MPa 0.2483.8 4. 2 3.3 0.5598.0 8. 9 7.1 1.05.9 6. 9 4.5 Figure 5 shows the image across the brain for the first of the sonications and demonstrate tissue damage indicated T2 changes. The tissue damage was also visible in Tl images with and without contrast enhancement.

To measure the phase distortion caused by the skull, a hydrophone was placed in the geometric focus of the array under test. The skull was placed between the array and hydrophone and each transducer element was powered separately in sequence while recording the time difference between the reference signal and the acoustic wave at the focus. This was done with both of the arrays. The phase changes required to correct all of the waves to arrive at the same phase at the focus are plotted in Figure 6.

To investigate the effect of the phase correction the pressure amplitude distributions were measured in water by scanning the needle hydrophone. The main impact of the phase at 0.6 MHz was in the location of the focus which could be corrected back to the geometric focus. This is shown in Figure 7A, which illustrates the pressure amplitude profile across the focus of the 0.6 MHz phased array in water.

Figure 7B shows the pressure amplitude profile across the focus through bone. And, Figure 7C shows the pressure amplitude profile through bone when a phase correction according to the invention is used. Figure 8 likewise illustrates the pressure amplitude distribution along the central axis of the array with and without phased correction. The magnitude was reduced to 33 % and 40 % of its water value without and with the phase correction, respectively. The importance of the phase correction

was demonstrated more clearly with the higher frequency array. With this array the focus was completely destroyed by the skull (Figure 9b). However, when phase correction was introduced, the focal spot was returned into its original shape (Figure 9c) with the half-width of the focus of about 1 mm. The insertion of the skull reduced the peak pressure at the focus of the 1.58 MHz array to about 5 % of its water value when phase correction was applied.

The embodiments of the invention discussed above and shown in the drawings provide improved methods and apparatus for neural diagnosis and therapy through application of short, high intensity ultrasound beams that induce cavitation at selected locations within the brain. These and other embodiments can be beneficially used to deliver focused ultrasound beams to the CNS tissues and fluids, thereby, permitting their ablation or other physiological modification. Thus, for example, the embodiments can be used to ablate tumors, cancers and other undesirable tissues in the brain. They can also be used, for example, in connection with the technologies disclosed in copending, commonly-assigned U. S. Patent Application No. 08/711,289 (the teachings of which are incorporated herein by reference) for modification of the blood-brain barrier, e. g., to introduce therapeutic compounds into the brain. Because they do not require that portions of the skull be removed, the embodiments permit the foregoing to be performed noninvasively.

The results also show that adequate ultrasound transmission can be induced through human skull to induce cavitation in vivo. This can be done with single element applicators, e. g., preferably at frequencies less than 1 MHz and at higher frequencies with phased arrays that correct the phase distortion caused by the variable thickness of the skull.

The maximum pressure amplitude of 8 MPa induced through the skull at 0.559 MHz was able to induce cavitation damage in vivo rabbit brain. This value was reached through an area of 10 cm in diameter to a focal spot diameter of about 5 mm (50 % beam diameter). If the whole available skull surface around the brain is

utilized, then a window of at least three times larger could be used. In addition, the geometric gain would allow the peak power through the skull to be increased.

Acoustic power up to 30-80 W/cm2 of the transducer surface area for continuous wave sonication can be generated by ceramic transducers. Higher peak powers could be achieved with the pulsed sonication used for induction of cavitation. Thus, it is estimated that much higher pressure amplitudes than measured here can be induced in the brain through the skull.

The values measured in connection with the foregoing compare favorably with the 4 MPa that was reported to be the threshold value in vivo muscle at 0.6 MHz and a value of 8.5 MPa at 0.936 MHz in vivo rabbit brain (the threshold at 0.6 MHz would be lower since it has been shown to decrease with frequency). Thus, the results demonstrate that adequate ultrasound transmission through skull can be generated to induce cavitation in the brain.

Our results demonstrate that low frequency beams can be focused through the skull, though, the focus may be shifted from its geometric location. Therefore, it can be helpful to detect the focal spot location in the brain prior to the therapy exposure, e. g., using magnetic resonance imaging to detect the local temperature elevation or cavitation in the brain at exposure conditions that are below the tissue damage threshold. For example, low power test exposures can be delivered through the skull while using MRI to detect the location of the focal spot. Based on the imaging information the location can be corrected to overlap the target volume prior to the therapeutic exposure.

The phase measurements with the arrays support the observation made with the single element transducers showing that at 0.6 MHz 80 % of the phase errors caused by skull are less than 900and thus, each wave is adding to the pressure wave at the focus. However, at 1.58 MHz over half of the waves had phase shifts that caused the waves to arrive out of phase at the focus. This observation can be explained by the difference in wavelength that is 2.50 mm at 0.6 MHz and 0.95 mm at 1.58 MHz

The possibility of inducing selective thermal damage at the focus, without damaging the skin or brain surface, may be possible due to the small focal spots achieved with the phase correction. However, the thermal exposures have to be short to reduce blood flow and perfusion effects that are strong in brain tissue. The sharp temperature gradients at the focus transport more energy away from the focus than in the bone where the beam is wide and the gradients shallow. At 1.58 MHz, full utilization of the skull surface may provide marginally adequate geometric gains to overcome the skull heating problem. However, at lower frequencies especially around 0.5 MHz the focal brain tissue thermal therapy seems feasible although not as likely as utilization of cavitation effects.

The results demonstrate that the effects of the skull to the beam shape can be eliminated using a phased array with proper phase corrections. In the example above, the phase correction was calculated from hydrophone measurements. The same corrections can be made by measuring the skull thickness from CT or NI scans and then calculating the phase correction required for each array element. The same may be accomplished by sending a short ultrasound pulse from each or selected elements of the of the phased array and then listening for the echo back from the inner surfaces of the skull or other structures in the brain. The effect of the skull on the wave propagation at each location could then be calculated. This can also be done before therapy by mapping the skull effect using ultrasound.

Although good results were achieved with only 60 transducer elements in the phased array, still more and smaller elements may facilitate moving the focal spot inside of the brain. Similarly, at higher frequencies, smaller elements may allow better phase correction further reducing the losses induced by the skull.

Thus, the geometric gain of about 20 that is required to compensate for the losses caused by the skull can be easily achieved by focusing. This is larger than the gain of 10 required to compensate the average losses. This indicates that adequate

power for induction of cavitation can be delivered using phased arrays through the skull even at frequencies that are too high with a single element applicator.

In summary, the invention provides methods and apparatus for noninvasive diagnosis and treatment of the brain using cavitational mechanism and pulsed ultrasound. It permits adequate power transmission through the human skull can be induced to cause tissue damage while keeping the exposures in the overlying tissues below the cavitation threshold.

Those skilled in the art will appreciate that the invention can be applied for purposes of tissue ablation, as well as in other procedures where focussed ultrasound is desired. These include opening the board-brain barrier, activation of therapeutic agents, occlusion of blood vessels, disruption of arteriosclerotic plaques and thrombi, etc. It will also be appreciated that the invention can be applied for treatment of humans, rabbits and other animals. The embodiments discussed above and shown in the drawings are illustrative only. Other embodiments, incorporating substitutions, modifications and other changes therein, fall within the scope of the invention. These include embodiments with transducer arrays of different sizes, shapes and numbers of elements, as well as embodiments with different amplification and driving systems.

In view of the foregoing, what I claim is: Buchanan et al,"The Design and Evaluation of an Intracavitary Ultrasound Phased Array for Hyperthermia,"IEEE Trans. Biomed. Eng., v. 41, pp. 1178-1187 (1994) Attachment I to Patent Application for Methods and Apparatus for Delivery of Noninvasive Ultrasound Brain Therapy Through Intact Skull Design and Experimental Evaluation of an Intracavitary Ultrasound Phased Array System for Hyperthermia Mark T. Buchanan and Kullervo Hynynen Abstract-For evaluating the feasibility of treating prostate cancer, a 64-element linear ultrasound phased array applicator for intracavitary hyperthermia was designed and constructed.

A 64-channel ultrasound driving system including amplifiers, phase shifters. and RF power meters was also developed to drive the array. The design of the array and driving equipment are presented, as are the results of acoustical field measurements and in vitro perfused phantom studies performed with the array.

Several techniques for heating realistically sized tumor volumes ivre also investigated, including single focus scanning and two techniques for producing multiple stationary foci. The results show that the operation of the array correlated closely with the theoretical model. When producing a single stationary focus, the array was able to increase tissue temperature by 12°C jsl vitro in perfused phantom. With some minor improvements in array design, intracavitary phased arrays could be evaluated in a clinical envtronmcnt.

1. INTRODUCTION NTRACAVITARY ultrasound arrays offer an attractive<BR> means of inducing local hyperthermia in deep-seated tu- mors located near body cavities. By locating the radiators as close as possible to the treatment site, problems frequently encountered with external techniques, such as blockage of the acoustic window by bone or gas, or simply the inability to attain adequate energy penetration, can be avoided. Early . results using multielement, nonfocused arrays of half-cylinder transducers operating at 1. 6 MHz suggest that such arrays can be clinically useful in the treatment of prostate cancer t 11.

The proximity of the prostate to the rectum wall makes it a good candidate for beating using intracavitary ultrasound radiators. Since the prostate is located very near the anus and only millimeters away from the rectum wall. an applicator can be easily located close to the prostate. The prostate is one of the most easily accessible tumor sites, and one that affects a large enough population of patients to be potentially clinically useful. As such, most of the experiments were conducted with the goal of heating the prostate in mind.

While the nonfocused arrays have shown considerable po- tential in heating the prostate, they have two primary lim- Manuscript received November 17. 19y2 : revised Aueust 9, 199. 1. Thia work w : ts supposed by grant number ROI CA 4fi919 jrotil the Nulional Cancer Institute.

The authors are with the Department of Radiology, Division of MRI.

B : igham and Women's Hospital, Harvard Medical School, Boston, MA 021 t5 USA. tEEE Log Number 9406164. nations : the depth to which they can effectively heat. and their limited ability to control the power deposition fields (2). [3j. Both deeper penetration and increased control over the power deposition pattern can he achieved using linear phased arrays. Since phased arrays can focus their radiated energy, they theoretically could heat tissues to therapeutic temperatures deeper than nonfbcused arrays. The ultrasound power deposition pattern can be electronically tailored as necessary to produce therapeutic temperatures within a dcsired volume. In areas where heating wou ! d be undesirabte. the phased array could take advantage of destructive interference to minimize power deposition at those locations. The ease by which the power deposition pattern can be electronically <BR> <BR> almrcd in real timc providcs a means 1'or the compensating for varying physiological parameters, patient positioning, and for minimizing patient discomfon.

Several types of utuasound phased arrays have been proposed or built for hyperthermic purposes. These include Umemura and Cain's sector-vortex and concentric ring appli- cators 14], {: S). the cylindrical section applicator developed by Ebbini c a/. [6). 17), as wlI as the tapered array developed by Benkeser e 81. Each Of these arrays is composed of anywhere from 16 to 64 individual elements and operates at frequencies between 5 () 0 kHz and 730 kHz-While these arrays show significant potential, they are meant to be used in extemal applications and therefore are unsuitable for intracavitary use in their reported configurations.

Previously, a theoretical study on the feasibility of intracav- itary phased arrays using half-cylinder elements had been done by Diederich and Hynyncn L3} Based on many acoustical and thermal simulations, it was concluded that a practical array would be composed of 30 half-cylinder elements with 2.5 mm center-to-center element spacing operating at 500 kHz.

The study predicted that the grating lobes formed with this array could be negated by using surface cooling. One of the major conxidcnuions in specifying this design was not the performance of the array. but the apparent high cost of the amplifiers necessary to drive the system. The desire to minimize the number of amplifiers led to the specification of a 30-element array.

Initial array designs were based on some recommendations from the theoretical study and expanded upon in an attempt to construct a practical intracavitary phased array. It became apparent that more than 30 amplifiers would be necessary for BUCHANAN AND Ht ; YNEN : INTRACAVITARY ULTRASOUND PHASED ARRAY SYSTEM COOOngWater Maziez zu CW jl wttter BoGy Eleeeodos Lv \, dz wO. D. 0. 0."_ Fig. 1.'the 64-elemeni artay and a single element showing the geometry ot the anay. The urt7y was mounted to a brass shell 19 mm in diameter. The back of the applicator was ; removable so that wires could be connected to the inner electrodes. a useful array. This led to the development of the 64-channel driving system to overcome the limitations imposed by the number of amplifiers. This allowed for the evolution of a 64- channel phased array with 1.73 mm center-to-center spacing and a total array length of 110. 5 mm operating at 500 kHz.

Il. MATERIALS AND METHODS A, Array Consn ztcrion A 64-element array was constructed using half-cylinder transducers operating in their resonant radial mode at 500 kHz.

The array was made by slicing washer-shaped elements with a diamond wire saw (Laser Technologies. North Hollywood.

CA) from 15 mm O. D. by 30-mm long cylinders of PZT- 4 material (EDO. Salt Lake City, UT) with silver electrodes plated on both the inner and outer wall surfaces. The transducer slices were glued together using a silicone adhesive (Dow Coming, Midland, MI) with 0.17-mm thick silicon rubber spacers (SPC Technology, Chicago. IL) between each element (producing a dead space of 0.23 mm between elements). The stack of elements was then cut in half along the axis of the cylinder and the two half-cylinder sections glued together to form the full array. The array was bonded to a brass shell to form the complete applicator, as shown in Fig. 1. Wires were soldered to the inside wall of each array element that extended the length of the shell to the handle where they were each connected to a 2-m RG-178 coaxial cable. The electrodes on the outer surface of the array were electrically connected by single wires embedded in beads of silver epoxy (Chomerics, Wobum, MA) running along both edges of the array.

B. Driving Hardware One of the primary disadvantages of phased arrays is the increased complexity of the driving equipment. Due to a lack of commercially available equipment to drive the array, a 64*channel amplifier system was developed. This system is composed of phase sbifters/duty cycle controllers, amplifiers, RF power meters. and impedance matching networks (see block diagram in Fig. 2) and is controlled by an IBM PC compatible computer via a digital I/O intcrface.

The amplifiers are based on a switching MOSFET design and are designed around International Rectifier's IR2110 dual MOSFET driver. Each of the amplifiers is capable of de) iv- ering up to 16 W of RF power at 500 kHz into a 50-W load from each channel or a total output power of about 850 W.

The amplifiers convert digital logic input signals into high power sine waves while preserving the phase of the input signal The amplitude of the output signal is controlled by two methods : All of the amplifier outputs can be controlled simultaneously by adjusting the output voltage on a 1000 W DC supply, or the output of each channel can be individually controlled by varying the duty cycle of the input signal. The result of reducing the duty cycle of the input signal (the duty cycle is the percent of"on"time of the input signal per clock cycle) is a corresponding decrease in the amplitude of the output signal.

Since the amplifiers require digital input signals, the phase shifting and duty-cycle control is implemented using digital ; ounters [10], [ll]. These circuits provide 22.5° phase shift resolution from 0-360'. and 16 steps of duty cycle (amplitude) that allows the output to vary from 0-100% of the output power. as allowed by the voltage from the DC supply. While the phase shift resolution may seem somewhat limited, studies have shown that it is sufficient for the uses described here fil))(12).

The actual RF output power from each channel is monitored by power meters that measure both the forward and reflected RF power [13]. The power meters,. which were also designed l Ssx l =X DaW Y ObAICOMd PaweliyppH T c<mm<t. * « f SD and OSA Canenr Ovdrtx out a m C. Rfo". AqwAws RI W.. i a w uoG wIOAYC101 r.. w (o' QODw run -rr pu r Mttna i zsr » (b) Ei3 lal (b, Fig. 2. (a) Block diagram of the ph : sed arraN drivinrx yslem. (h) A himpkiñed Scbcm : of the swilching amplifiers. TABLE) NOME>CLATURE AND DP, EAULT VALUES USED jN THE NUMERICAL STUDIES f frequency 500 kHz e velocity 5 Np m' CL Radius of simple source X/32 i wavelength 3.0 mm and constructed in house, allow for verification of the output power on each of the amplifier channels, and allow for the monitoring of the output: so that possibly dangerous fault conditions do not occur. B monitoring the amount of<BR> reflected power. changes in the electrical matching and the array operation can bc easily n : unitorcd so that peak array performance can be maintained.

Finally, to maximize power transier between the amplifiers and array elements. a simple LC impedance matching network was used on each channel between tne poaer meters and the array. This not only maximizes power transfer, but ensures greater uniformity in the acoustical output signals for a given excitation phase and amplivude. e,. ied experimentally by a needle hydrophonei. Without matching, the phase shift and amplitude distortion ci-m by the impedance dif- ferences between elements in . t T would have to be characterized using a hydrophone and the results used to compensate the excitation signals.

C. Acoustic Modeling The 3-D ultrasound modeling program used was originally developed by Diederich and Hynynen (3) and is only briefly introduced here. The routine models N cylindrical radiators of finite length, radius and separation as each of the ultrasound transducers in the array, and assumes a target media having similar acoustical properties as tissue (Table t). The routine models the surface of each of the cylindrical elements as an evenly spaced grid of simple hemispherical sources and uses Huygens principle to sum the contributions of each source at each point in the field. All of the simulations were done with the sources spaced on a 1/32 grid.

The acoustical pressure field was calculated in the z-plane using and n, is the number of sources in the 7-direction, ne is the number of sources in the theta direction, P, is the pressure from a single source (Pa), P,,, is the pressure amplitude at the surface of the source (Pa), r. is the radius of the source (m), r is the radial distance from the center of the source (m), l is the wavelength (m). 0 is the phase of the excitation signal (rad), f is the operating frequency (Hz), and a is the attenuation coefficient (Np/m).

D. Foc'usin, q Tecfmiyttes The single focus case is the simples form of focusing that can be done with a phased array. The single focus is produced by setting the phases of the driving signals so that constructive interference occurs at the desired focal position. The phase of each of the driving signals for an array with N elements can be calculated from the differences in the path lengths di between each array element and the focal position by where/, is the phase (radians) of the ith element, I is the wavelength (m), i = l, 2,..., N and m = 0,1,2,.... The size of the focus produced with this technique is usually too small to heat an entire tumor volume, and therefore other techniques must be used to heat larger volumes.

To heat larger volumes, two techniques were investigated: single-focus scanning and multiple focusing. The single focus scanning routine simply stepped a single focus back and forth along a predetermined length of the array. The focal depth was kept constant while the focus was stepped every 300 ms to the next position in the scan. Delivered power was maximal at the edges of the scan but was reduced to 64% of maximum power at the center of the scan to flatten the temperature distribution in the perfused phantom experiments (the power distribution was experimentally determined).

The other technique, multiple focusing, simultaneously pro- duces more than one focus within the target volume. The driv- ing signals necessary to produce multiple foci were calculated using two techniques: split focusing and the pseudo-inverse.

To create multiple foci with the split focusing technique, the array was divided into subarrays, each of which produce a single focus in the same manner as previously described. The pseudo-inverse method, developed by Ebbini and Cain [IS], uses a series of control points that represent the magnitude of the ultrasound field at given points. A brief summary of Ebbini and Cain's technique follows.

The technique solves the Rayleigh-Sommerfeld integral for an array with N elements, and a field of M control points p (r) where p is the density of the propagation medium, c is the speed of sound in the medium, k is the wavenumbcr, S'is the surface of the source, Un is the particle velocity normal to the surface of the source, and rm-rn is the distance between a control point (err) and the surface of a source (r-n), m = 1, 2,."M, and r = It 2,."N.

To simplify programming of this algorithm, (4) can be described by where u is the excitation vector, p is the complex pressurc at the control points, and H is the remainder of (4). For intracavitary hyperthermia uses, the number of elements in the array (JV) is always greater than the number of control points (M). This leads to an underdeterrnined system of equations with an infinite number of solutions. The minimum norm solution (u) can be determined by using a least squares approximation of (5) where II"is the compJex conjugate of H. With this technique, all of the array cements contribute to a) l of the foci. unlike the split focusing technique where each element contributes to only one focus.

111. EXPERIMENTAL TECHNIQUES A. Acousrical Efficiency Measurements The acoustical output of the cylindrical transducer elements was measured using a radiation force technique (161. The array was placed in a brass cone with 45° sides to reflect the radially emitted ultrasound fields down into the acoustical absorber [17]. The force on the absorber was measured using a Metler AE 160 (Hightstown, NJ) microbalance, while the RF power was measured using a Hewlett Packard 438A RF power meter and a Weriatone C2625 (Brewster, ! dual<BR> directional coupler. The efficiency was calculated as the ratio of the acoustical power to the RF electrical input power.

B. Ultrasound Field Measurements The ultrasound fields were mapped in a tank of degassed, deionized water by mechanically scanning a thermocouple embedded in a small (2-mm diameter) plastic sphere. The ther- mocouple was positioned by a three-axis computer controlled scanning table. The applicator was mounted on a rotational device that allowed measurements to be made in a radial arc around the array by rotating the array. Measurements were made on a 1 x 1 mm grid with the recorded data being the average of three consecutive measurements.

C. In Vitro Kidney Experimenrs Alcohol fixed canine kidneys were used as phantoms for studying the heating characteristics of the array. The kidneys had previously been prepared as described by Ho) mes er al. [18], and were rehydrated prior to use. The experiments were conducted at room temperature using degassed, deionized water as the perfusate. A metering pump IFiuid Metering Inc., RHICKC, Oyster Bay, NY) connected to the renal artery circulated water through the kidney while the renal vein was allowed to drain into the tank. The kidney was held in place by gently sandwiching it between two PVC membranes mounted to a Plexiglas frame. The applicator was firmly clamped to the frame to maintain a fixed distance between the surfaces of the kidney and array. Fig. 3 shows a diagram of the experimental setup.

Temperatures were measured in the kidney using either seven sensor probes sutured in place perpendicular to the array through the focal region, or by one or two single sensor thermocouples pulled along a path parallel to the array. In experiments conducted with the multiple sensor probes. the kidney was exposed to ultrasound for a total of 10 min with temperature measurements occurring every 30 s. During each temperature measurement, power to the array was disrupted for approximately four seconds (one second prior to the first reading. and up to three seconds to read all of the thermocouples). Since this technique does not sive very fine spatial detail of the temperature distributions, the pull-back technique was more frequently used.

The pull-back experiments were conducted by pulling one or two single uncoated thermocouples (0. 05-mm wire) by a computer controlled stepper motor along a track parallel to the array through the kidney tissue. The temperatures were measured every 1 mm and the average of three readings was recorded. Prior to each of the experiments, a baseline tem- perature was established along the path of the thermocouples.

The kidney was exposed to ultrasound for 20 min to allow the temperatures to reach steady-state before the temperature profiles were measured. The difference between the baseline and final measurement was used to calculate the temperature rise. The kidney was allowed to cool to room temperature (typically, 30 min) before to the next experiment was started.

The thermocouples were mainly located in the medulla of the kidney. The steady-state temperatures in the medulla have been shown to be a strong function of the flow into the kidney [19]. The How values were kept relatively low in order to simulate the perfusion in the prostate [20], [21].

IV. RESULTS A. Acoustical Efficiency Measuremenrs The acoustical efficiency of the 500-kHz PZT-4 transducer material was measured for a full cylinder, 30 mm long. and for two half-cylinder arrays with 2. 5 mm and 1. 8-mm center- to-center element spacing (2. 2 mm and 1. 5 mm element widths) with total array lengths of 24. 7 mm and 28.5 mm. respectively. Small arrays were tested so that the resulting field would be collimated, unlike a single array element r PVC WU Absorbtw Ahaner n : \ <, I I i,, aa, r Pertuslon rump Ciraetinp Pumc Wys Beh Fig. 3. Diagpm of the i virrc) kidney expeomentat setup. 20 w -t. txm '-t. txm 1. 11T is .. 1S-., B _.. . 10 3_,. i' S' U cul 10 0. 2... _ *- ,. _.,. _.... _... _......... _. 0 s 10 Is 20 25 30 Eleclrical Power (W) Fig. 4. Acoustical output pOWer as a function of electrical input power for a single 30-mm. full cylinder element and arrays made up of 16 2.2-mm and 1. 5-mm elements with a 0.3-mm insulator between element.

(width < wavelength), which would produce nearly spherical wavefronts. The collimation is necessary to assure the waves reflected by the reflector are normally incident to the surface of the absorber.

The results of these experiments are shown in Fig. 4. None of the arrays exhibited very high efficiencies despite the low operating frequency. Though not shown here, some results were verified using calorimetric techniques. While the 30-mm long full cylinder clement had an efficiency of 71 %, the arrays exhibited efficiencies of 27% and 17% for the 2.2-mm and 1. 5- mm arrays, respectively. These efficiencies indicate that about 80% of the electrical power delivered to the 1. 5-mm wide elements used in the phased arrays is lost either as heat in the transducer or in the electrical matching and transmission lines between the amplifier and the array.

B. Ultrasound Field Measurements The effects of element spacing were studied by measuring the ultrasound field distributions produced by two 16-element arrays with 1. %-mm and 2. 5-mm center-to-center element spacing. Fig. 5 (a) and (b) shows the acoustical field plots made in a plane parallel to the array and normal to the surface of BUCHA. N. KN AND HYNYNEN : INTRACAVITARY ULTRASOUND PHASED ARRAY SYSTEM 2S25 20 20 is 10 10 1C . 5 . ° f o °-5 -ZD-20 . 15-15 . 20 _20 5 10 15 20 25 30 35 40 4S 50 SS 5'10 t5 20 25 3D 35 40 46 Sp 55 (a) (b) 25 25 20 Zp is Is io 10 E 1U 5 U O a -s _s -20 . 25 e 1 5 10 16 20 25 30 36 ap a5 5p 55 S 10 15 20 25 30 35 AO zu SO 55 Rodas Distance (mm) Hadlel Oletere (mm) (c) (d) Fig. 5. Field plots in water of two 16-element arroys with l. 8-mm (a) and 2. 5-mm (b) element center-lo center spacing xnd their corresponding simulation reaults Itc and (d)). Both arrays were focused 30 mm from th arry surtucc and 15 mm-from the central axis. the half cylinder elements for two 16-element arrays with 1. 8- mm and 2. 5-mm element spacing along with their respective simulated fields (Fig. 5 (c) and (d)). Both arrays were focused 30 mm from the array surface and 15 mm above the central axis of the array. The most significant effect illustrated here is the generation of the grating lobe by the 16-element array with 25-mm center-to-center element spacing (Fig. 5 (b) and (d)).

Since such a large grating lobe not only reduces the power of the focus but also could cause heating in unwanted areas, arrays must be designed to minimize grating lobe formation.

The array with 1. 8-mm center-to-center spacing produced much better field distributions than the array with 2.5-mm center-to-center spacing. Therefore, in order to have center- to-center spacing 1. 8 mm or small,). 5-mm wide elements were used in the final array design and the dead space between elements was reduced to 0.23 mm The complete measured and simulated plots of the ultra- sound field produced by the 64-element array with 1.73-mm element spacing are shown in Fig. 6 (a) and (b), respectively.

The array was focused 40 mm deep, and 30 mm from the central axis. Note that only a small grating lobe is produced by this array even though it is focused a substantial distance from its central axis. In fact, this array is capable of focusing to about 35° from the central axis of the array without producing significant grating lobes.

So far. all of the acoustical field measurements presented have been in a plane parallel to the length of the array and normal to the surface of the array. Ideally, the acoustical field would taper off toward the edges of the array but be more or less uniform around the arc of the array. Unfortunately, this ideal does not match reality, as can be seen in Fig. 7. The acoustic field was measured as a function of rotation angle along a line by fixing the position of the thermocouple in the focal region and rotating the array about its axis. The acoustical intensity is not at all uniform and, in fact, varies as much as 50% before tapering off at the edges. All of the 2-D acoustical field plots shown here were made at the 0° rotation angle where the intensity is only about 50% of the peak. Measurements made, but not shown here, show that this fluctuation in pressure amplitude due to the rotation angle only alters the peak intensity and does not effect the overall shape of the acoustic field.

Fig. 8 (a) and (b) shows the acoustical field plots produced using the two multiple focus techniques: pseudo-inverse and split focusing. Below them, in Fig. 8 (c) and (d), are their respective simulation results. Both techniques were used to synthesize foci 40 mm from the array surface and 10 mm on either side of the central axis of the array (20 mm apart) using the 64-element array. Notice that the pseudo-inverse technique produces sharper foci than those produced by the 60 4 il, zu o,,. _. 0 0 viz E E 20 . L . 20 0 0. p -2p 20 0 0 -60 5 IS 25 as 45 ss es 5 is zs as AS ss as Rec6sl Distsnce (rtwrl) RaCial plsrence (mm) (a) (b) Fig. 6. Field plot of the 64-element array (a) along with the simulation results (b) for focus 40 mm from the surface of the array and 25 mm off its central axis. 1*o z olé y o.B 0, 0.'7 0.w- 0. s b sla O. 4 ~ I. 2 X 0. 2 = . y 0. 1-jl i,. \ _ 0. 2 _ 90 75-60-45-30-15 0 15 90 IS 60 75 DO Rotetional Angle (Degreas) Fig. 7. Single dimcnsional radial ñeld plot made within the focus as a function of the angle of rotation of the array. The center of the array arc is defined as the zero point. split focusing method. This occurs because the pseudo-inverse technique utilizes the entire length of the array allowing it to produce sharper foci than the split focusing technique which, since it divides the array into two subarrays, effectively uses array lengths only half as long as the actual length of the array.

C. In Virwo Kidney Experimeslts Fig. 9 (a) shows the temperature né versus time along a fixed seven-sensor thermocouple probe located perpendicular to the array. The distances marked denote the distance of the thermocouple from the edge of the kidney nearest to the array. The array, with 32 active elements, was focused along its central axis and 10 mm into the kidney, (Thirty- two active elements were used since the array length in this configuration could adequately cover the kidney.) The kidney was perfused at a rate of 2.9 kg m-3 5-l. Note that the kidney is only 35 mm thick and thus. the temperatures close to the surfaces of the kidney are dominated by cooling caused by the circulating water in the water bath. All of the following results were obtained in the center of the kidney where the focus was located and the surface effects were smallest. The temperature rises achieved in the middle of the kidney indicate that therapeutic temperatures can be achieved with a stationary single focus at realistic perfusion levels. Typical cross-section profiles measured in the middle of the kidney with the pull- buck technique for a center focus and 15 mm on either side are shown in Fig. 9 (b).

The three different techniques for heating larger volumes: pseudo-inverse, split focusing, and scanned single foci arc compared in Fig. 10 (a) and (b). The two multiple focusing techniques were used to produce foci 40 mm from the surface of the array and 10 mm on either side of the array's central axis. while the scanning routine produced a series of single foci 40 mm from the array surface with a total span of 20 mm. The thermocouples were located 8 mm and IS mm from the surface of the kidney nearest to the array (35 mm and 42 mm from the surface of the array). The scanning technique produced a narrower profile than the two multiple focusing techniques and the distribution lacks the temperature drop between foci. The two multiple focusing techniques produce virtually identical profiles, although the pseudo-inverse technique does not produce as large of a temperature rise on the deeper thermocouple (beyond the focus) as does the split focusing technique. This is caused by the increased sharpness of the foci produced by the pseudo- inverse technique, as previously explained.

V. DISCUSSION AND SUMMARY An intracavitary ultrasound phased array composed of half- cylinder transducer elements has been constructed for inducing hypenhermia in the prostate via the rectum. A 64-channel amplifier system has also been designed and constructed to drive the phased array. As was shown by the acoustical field plots, the array is capable of producing focused fields as well as fields containing more than one focus. The array is currently capable of producing a 12°C temperature rise in a perfused phantom using a stationary focus, and smaller temperature ex su AO 40 . _'_. 20 2p. _. _,. U n V. % , v , o v W a O t S Is 25 35 45 55 65 5 15 2S 35 4 55 65 (a) (b) SOzu 40 40 g D L 20 < E- V- -2D. pp 40 p , 5 15 25 35 45 55 as 5 15 25 35 45 55 65 Radlal DWUnoo (mm) iew ru (mm) (c) (d) Fig. 8. Acoustical field plots produced using the pseudo-inverse (a) and snlit focusine (b) techniques and the related simulated result ( (c) and (<t)). The foci were produced AO mm deep, and to mm on either side of the central axis of the array. increases were achieved in larger volumes by scanning the focus or by creating multiple stationary foci. This was achieved with flows to the kidney that should simulate the relatively low perfusion in prostate [20], (21).

What has yet to be conclusively shown is such an array's ability to heat tissues to therapeutic temperatures in a regu- lar and predictable manner. The peak temperatures achieved within the perfused phantoms tended to vary considerably from experiment to experiment, making direct comparisons between the absolute temperature profiles difficult. Therefore. the tem- perature profiles that compare various focusing techniques were normalized to better illustrate the overall differences in the shape of the temperature profiles. The fluctuations in temperature were caused by a variety of problems, including morphological differences in kidneys and the location of the thermocouples within the kidneys, the inefficiency of the array, and the open loop manner in which the array was ooerated.

The electrical efficiency of the array would usually drop considerably during the first experiment, and during each sub- sequent experiment due to changes in the electrical impedance of the array elements. Two primary factors were responsible for the observed changes in the electrical impedance of the array elements: The first was a thermally induced impedance drift caused by the array self-heating during sonication. The second impedance shift that occurred from experiment to experiment because the impedance of the array elements did not return to their original impedance after cooling. The impedance shifts made it difficult to accurately control the radiated power delivered to the kidney. Other problems with the array included arcing between elements and water seepage behind the array that reduced the array efficiency in subsequent experiments until the array was repaired and rematched. With a more carefully constructed array, most of the power limiting problems experienced can be avoided.

The acoustical field plots were in good agreement with the theory, and the techniques for heating larger volumes were all functional, though the multiple focusing techniques were the most effective. Overall. phased arrays show considerable potential for improvement over currently used intracavitary ultrasound hyperthermia system.

While phased arrays allow significantly more control over the acoustical field, the current design using half-cylinder radiators still lacks control in the angular direction (around the arc of the array). Additionally, since the cylindrical radiators do not have uniform angular intensities, the angular heating pattern is somewhat degraded, though thermal conduction will probably smooth the resulting temperature distribution. Similar fluctuations in the angular field distributions have been shown for other cylindrical transducers [2], [l 1]. Radial control could be achieved by dividing the half-cylinder elements into 10 5 mm zozo 15 to mm a. ? 26 mu '-°-' "" O, 1--owMno --tb mm o--YO nm , oJ oui '- so wn ;, o. e z ° 1 E O. 6 ° a o e O. I o 8 E t o. t o. o a w io so o so eo 0 MO 2M MO <M SCO 000 700 <00 A : isl Dlloo (mm) Time (s) (a) (a) . o . o -pil1 0. 8--Is mm 0. 7 A 0. 6 e EOz5~ J A \ S02 0. 6 : o. e o. s law 0. 2 e C. 6 e 0.1 e N N C E 0, = 0. t _° 0. 2 a. 1 p, 0. 0 0 10 20! 0 10 50 10 0.0 AxisOtstance (mmj O 10 20 90 10 Adl Olstnce (mm) Fig, 10. Normalized temperuurc/power profiles measured in a perfused kidney for multiple focusing using the pseudo-inverse and split focusing Fig, 9. Temperature profiie measured in a perfused kidney using 32 ective « hniques, ae well s single-focu : acanning. 'he multiple foci were created elements focused 30 mm from the array surfacc while the kidney was perfused 40 mm decp. 10 mm on cilher side of thc central axis while the scanning etemMM focused 30 mmfm th. ay. urfac. h,) ethc X. dney a.. p. rfud , 0 .. atthe rate of 2, 9 ke fn-v s- (5 mL min- Now). Tho array Was Dosieioncd °es done With a single focus 40 mm deep, and scanned 10 mm on eitlter I8 mm from the kidney surtace. The thermocouple lacations indicate the ye f the central axis. The mexurcmcms wcre mnde 8 mm (a) and 15 mm distance from the surface of the kidney, (a) The axia) dMtribunon measured . f 12 mm from the surface of the kidney using 3 pull-back thermocouple (b) in kidney surface. a separate expcriment. pie-shaped subeiements and driving each subelement indepen- dently. However, this would not only dramatically increase the number of amplifiers, but the resulting subelements would have virtually no inner electrode due to the wall thickness of the element. This would seriously degrade the already low acoustical efficiency of the cylindrical radiators.

A possibly better array design would utilize planer array elements mounted on a rotating platform. By tilting the array back and forth, the same volumc could be treated as with the cylindrical radiators. By controlling the acoustic field and output power as a function of tilt angic, 2-D control over the power deposition field can be achieved without requiring additional amplifiers. An additional improvement on the array design would be to increase the operating frequency. While the 500-kHz operating frequency allowed larger element sizes and minimized grating lobc formation, higher frequencies would increase the power absorption in tissues. Since most tumor sites for which this applicator would be used occur near the cavity wall. the deep penetration allowed by the 500- kHz operating frequency is not necessary. The difficulty in increasing the operating frequency is that the element size and center-to-center element spacing would need to decrease as the frequency increased, making array design more difficult.

As a conclusion. the intracavitary, electrically focused array did demonstrate, at practical depths for prostate treatments (about 30 mm), the feasibility of using phased arrays for intracavitary hyperthermia purposes. With a more carefully constructed array, most of the power limiting problems ex- perienced can be avoided. The acoustical field plots were in good agreement with the theory, and the techniques for heating larger volumes were all functional, though the multiple focusing techniques were the most effective. Overall, phased arrays show considerable improvement over the currently used intracavitary ultrasound hypertbermia system [1]. However, it does not offer power control in the angular direction (around the axis of the applicator) and thus, new designs allowing 3-D control of the power field should be developed before clinical testing.

ACKNOWLEDGMENT The contents of this article are solely the responsibility of the authors and do not necessarily represent the official views of the National Cancer Institute. REFERENCES H. Fosmire. K. Hynynen. G. W. Drach, B. Stea, P. Swift, and 1. R. Cassady."Feasibility and toxicity of transrectal ultrasound hypenhermia in the treatment of locally advanced adenocarcinoma of the prostate." Int. J. Radiarion Oncol. Biol. Phys.. submitted 1992. (2] C. J. Diederich and K. Hynynen,"Induction of hyperthennis using an intracavitary multielement ultrasonic applicator."IEEE Trans. Biomed. Eng., vol. 36, no. 4, p. 432. 1989. [3),"The feasibility of using electrically focused ultrasound arrays to induce deep hyperthermia via body cavities:' IEEE Trans. Ultrason. Ferroelec. Frequency Conir., vol. 39, no. 3, pp. 207-219, 199). [41 C. A. Cain and S. 1. Umemura."Concentric-ring and sector vortex phased-array applicators for ultrasound hypenhermia."/EEE Trans. Ul- reason. Fernelec. Frrquency Contr.. vol. UFFC-34, no. 5, pp. 542-551. 1986. (5)-,"The sector-vortex phased array,. Acoustic field synthesis for hyperthermia,;' IEEE Trans. Ulrroson. Ftrroelec. Frrquncy Conrr., vol. 36, no, 2, pp, 2a9-257, 1989. (6) E. S. Ebbini. S. 1. Umemura, M. lbbini, and C. A. Cain,"A cylindrical- section ultrasound phased-array applicator for hypenhennia cancer theapy ;'lEEETrons. 8iomed, Eng"vol. HM6-35, no. S. pp. 561-572. 1988. [7] E. S. Ebbini and C. A. Cain, 'Experimental evaluation of a prototype cylindrical section ultrasound hypenhermia phasedwarray applicator," IEEE Trans. Ultrason. Ferroetee. F"quency Contr.. vol. 38, no, 5, pp. 510-520, 1991. 510^520, 1991. [8] P. J. Benkeser. L. A. Frizzell. K. B. Ocheltree. and C. A. Cain."A tapered phased-array ultrasound tnducer for hyperthermia treatment;' IEEE Trans. Ultrason. Ferroelec. Frequency Conter., vol UFFC-34, no. 4, pp. 446-453, Cl987. [91 C. J. Diederich and K. Hynynen,"The development of imtacavitary uluasonic applicators for hypemermia : A theoretical and experimental study. Med. Phys., pp. 626-634. July-Aug. 1990. (1O] F. Ngo,"Ultrasonic phased-array driver syslom. M. S. Ihesis. Univ. of Illinois at Urbana-Champaign, 1988. (I 1] C. 1. Diedench,"7lte design and development of intracavitary ultrasound arrays for hypenhermia,"Ph. D. diascrtation, Univ. of Anrona. Tucson. 1990. [12] H. Wang and C. A. Cain."Effect of phase errors on field patterns generated by an ultrasound phased-array hypenhermia applicator :' IEEE Tranr. Ultrason. Ferroelee. Freguency Conrr., vol. 3B. no. 5, pp. 521-531, 1991. íl31. Digital PEP wattmeter and SWR calculator,"'in The ARRL Handbook jbr the Radio Amarer, B. Hale. Ed. Newington, CT : American Radio Relay League, 1989, pp. 34-10-34-15. [14] E. S. Ebbini and C. A. Cain."Multiple-focue ultrasound phased-array patternsynthesix : Optimal driving-sigl, s ! dlstdbutlons for hyperther- mia :' fEEE Traru. U trason. Ferroe (ec. fnquency Contr.. vol. 36, no, 5, pp. S4iO548, 1989. [151 E. 5. Ebbini,"Deep localized hypenhemur with ulaagound phased arrays using the pseudoimerse panez synthetic method,"Ph. D. dis- sertation, Univ. of Illinois. Urbana, IL, 1990. (16) H. F. Stewan,"Ultrasonic measurement techniques and equipment outputlevels,"in 6rseuin (s jMedinal Ulrrorowsal. M. H. Repacholi and D. A. Benwell. Eds. Clifton, NJ : Humana Press. 1982, pp, 77-116. [171 K. Hynynen."Acoustic poWer caiibraflons of cylindrical intncavitary ultrasound hypenhertnia applicators."Med. Phys.. vol. 20, pp. 129-134, 1993. [ìS] K. R. Holmes. W. Ryan, P. Weinstein, and M. M. Cben,"A fixation technique for or ; gans to be used as perfused tissue phantoms in bichost transfer atudies,"in 1984 AGvanca in Bioengineering. R. L. Spiker, Ed. New York : American Society of Mechanical Engineers. 1984, pp. 9-10. l91 K. Hynynen, D. DeYoung. M. Kundrat. and E. Moto !."The effett of blood perfusion rate on the temperature distribution induced by muluple. scanned and focused ultrasonic beams in dogs'kidneys in rivo,"/nt. J. Hyperthermia, vol. 5. pp. 4B5-497. 1989. (20) J.-E. Damber. A. Bergh. L. Daehlin. V. Petrow, and M. Landsuom. "Effects of 6-methylene progesterone on growth, morphology, and blood now or Dunning R3327 proscatic andenocarcinoma,"Prosrate. vol. 20, pp. 87~197, 1992, [211 O. Jonsson. A. Widmark. K. Grankvist. J.-E. Damber. and R. Hen- riksson,"Effeccs of clonidine-indueed hypenhension on blood flows in prostavic adenocarcinoma (Dunning R3327) and normal tissue." Prostate, vol, 20, pp. 225-232. 1992. Mark T. Buchanan was bom in Tucson. AZ, on August 16. 1967. He received the B. S. and M. S. degrees in electrical engineering in 1989 and 1991, rcspcctively. at the University of Arizona. He is currency continuing his ultrasound research with the Depanment of Radiology at the Brigham :, and Women's kToapsiil id BOSI6B, MA. ;, Kuttervo Hynynen was bom in Pyhimtii. Finland. in 195d. He received the M. S. degree from the University of Kuopio. Finland. in 1977, and the Ph. D. degree from the University of Aberdeen. Scotland. in 1982. From 1982 to 1983. he ! s a Postdoctoral Research Assistant at the University of Aberdeen, where he was developing a focused ultrasound system for the treatment of tumors. In 1984, he joined the faculty of the University of Arizona. where he reached the rank of Aswciate Professor of Radiation Oncology. In 1993, he became an Associate Professor of Radiology in Harvard Medical School and Brigham and Women's Hospital. His main research interests include theoretical and experimental development of high power ultrasound devices for therapy, and utilization of ultrasound and MRI to guide, monitor and control the energy exposure.

Fan et al,"Control of the Necrosed Tissue Volume During Noninvasive Ultrasound Surgery Using a 16-Element Phased Array,"Med. Phys., v. 22, pp. 297-308 (1995) Attachment II to Patent Application for Methods and Apparatus for Delivery of Noninvasive Ultrasound Brain Therapy Through Intact Skull Cbntrot of the necrosed tissue volume during noninvasive ulfrasound- surgery using a 16-element phased array Xiaobing Fan^) and Kullervo Hynynen Department of Radiofo, gv, Brigharn and w'amen'. H. rpita (. H6nard Medical Srhnnl. Baslon.

Massachuserrs02IlS (Received 24 March 1994 ; accepted for publication 31 October 1994) Focused high-power ultrasound beams are well suited for noninvasive local destruction of deep target volumes. In order to avoid cavitation and to utilize only thermal tissue damage,, high fre- quencies (1-5 MHz) are used in ultrasonic surgery. However. the focal spots generated by sharply focused transducers become so small that only small tumors can be treated in a reasonib) e time.

Phased array ultrasound transducers can be employed to electronically scan a focal spot or to produce multiple foci in the desircd region to increase the treated volume. In this anicle. theoretical and experimental studies of spherically curved square-element phased arrays for use in ultrasonic surgery were performed. The simulation results were compared with experimental results from a 16-element array. It was shown that the phased array could control the necrosed tissue volume by using closely spaced multiple foci. The phased array can also be used to enlarge a necrosed tissue volume in only one direction at a time, i. c,. lateral or longitudinal. The spherically curved 16 square element phased array can produce useful rcsults by varying the phase and amplitude setting.

Four focal points can be easily generated with a distance of two or four wavelengths between the two closest peaks. The maximum necrosed tissue volume generated by the array can be up to sixteen times the volume induced by a similar spherical transducer. Therefore the treatment time could be reduced compared with single transducer treatment.

Key words: phased array, ultrasonic surgery 1. INTRODUCTION In ultrasound surgery, to avoid cavitation and have a sharp boundary between the tumor and normal tissue, high fre- quency focused transducers have to be used. l The focal spots generated by sharply focused ultrasound transducers are small when compared with the diameter of many tumors.

Obviously this type of focus is not efficient to treat large tumors, which would require a large number of exposures to cover the whole target volume. However, in order to accu- rat- treat the target volume close to critical structures,<BR> s focal spots may be required during part of the therapy, Thus, controllable focal spot size is required. The most at- tractive method to obtain control over the focal spot size is to use phased arrays.

Phased array applicators were introduced to ultrasound hypenhermia cancer therapy in the early 1980's. During the past decade, many efforts have been made to investigate the advantages of phased arrays in hypenhermia, and several phased array applicators have been developed. Phased array applicators can be divided into the following categories: an- nular or concentric-ring arrays, 23 stacked linear-phased arrays, 4 sector-vonex arrays, 3 tapered linear-phased arrays, 5 cylindrical-section arrays, 6 and square-element spherical- section arrays. 7 It was shown that ultrasound phased arrays can provide good control over the heating pattern with flex- ibility in moving the focus and producing multiple foci. Pre- vious research in ultrasound phased arrays has been concen- trated in hyperthermia cancer therapy. Relatively low frequencies (about 0.5 MHz) and small element size (com- pared to the wavelength) were employed in these studies.

The studies on square-element spherical-section arrays em- phasized using a large number of elements, up to a few hun- dred. The main disadvantage associated with using a large number of elements is that the same number of amplifiers and electronic circuits are also required.

The motivation of this article was to demonstrate that a phased array system with a small number of elements can be utilized lo provide control over the focal spot size for surgi- cal purposes. The excitation signals of the elements vary in both amplitude and phase. Hence the major task in utilizing phased arrays is to determine the phases and amplitudes needed to produce desired ultrasound fields. The inverse technique introduced by Ebbini and Cain8 can be used for direct synthesis of ultrasound fields with multiple foci. Sev- eral amplitude and phase settings were calculated for differ- ent sets of selected control points, The limitation of the num- ber of utilizable control points was also investigated for a given array. Several simplified amplitude and phase settings based on the calculated amplitudes and phases were em- ployed for ultrasound field calculations. These driving signal sets can be utilized, when different focal spot sizes are re- quired for the array proposed here. The transient bioheat transfer equation was employed to estimate the temperature elevation due to the ultrasound power deposition. Then the necrosed tissue volume was predicted by the isothermal dose volume. Computer programs were also used to do a paramet- ric study to investigate the influence of the dimensions and frequency of the array on the necrosed Tissue volume.

If. MATERIALS AND METHODS A. Square-element array with spherical surface The phased array was made from a spherically curved transducer which was divided into small square elements.

The whole array was airbacked. It was constructed from a X fA S Z FG. I. Coofiguration of the square-element spherically curved phased array with its coordinate system, spherically curved PZT4 bowl, having a diameter of 100 mm. a radius of curvature of 130 mm. and a frequency of 1. 4 MHz. The bowl was cut into 16 elements, each with a length of 20 mm per side. A 0. 3-mm space between the elements was filled with silicone rubber for electrical and mechanical isolation. Each of the elements was connected to an LC matching circuit to match the impedance to 50 fl and 0°. The array was driven with a custom made 16 channel amplifier (Labthermics, Champaign. Illinois). The phase and ampli- tude were controlled by RF signals feeding the amplifiers.

The driving signals were generated by an in-house manufac- tured digital circuit. 9 The amplitude and phase of each input signal were digitally controlled with 3-bit resolution in am- plitude and 4-bit resolution in phase. The number of ele- ments in each row and each column were the same so that the whole applicator was a square shaped focused transducer.

The configuration of the phased array for the experiments is shown in Fig. 1.

B. Ultrasound field measurements The relative pressure amplitude squared distributions were measured in degassed water using a needle hydrophone (active spot size 1 mm) scanned across the focal region. The needle hydrophone was moved by stepper motors, typically with 0. 1-mm steps across the beam. The total acoustic power was measured using a radiation force technique.

C. Computation of ultrasonic fields Consider an ultrasound phased array with N elements. employed to produce an ultrasonic field in a nonattenuating medium. Assume the coordinate system is defined as in Fig.

I. According to the theory of ultrasonic radiators developed by O'Nell0 and the principle of superposition of acoustic pressure. the pressure field due to this transducer can be evaluated by the'Rayleigh-Sommerfeld integral. The inte- gral is JP<'A -71''"-'" where \/-t. p is the density. of medium, c is the speed of sound, k is the real wave number.'l"= A"ei ('+z) is the complex excitation source of the nth element with amplitude A, and phase din. rmn is the distance from. a point (x", y", z,.) on the nth element to the field point of interest (xm, Ym Zm) S,, is the area of the nth element. In ultrasonic surgery, water is used as a coupling medium between the transducer and tissue interface. Water is consid- ered a nonattenuating ! medium. and tissue a weakdy attenuat- ing medium. The effects of attenuation can be satisfactorily described by replacing c*-""'with '''-"'in expression (1), where k--k-ja is the complex wave number with at- tenuation coefficient ct. 11. 12 The power deposition for the desired volume is given by ! p. y- :) !' Q (x. y, z) =lt" Z. whera , b, is the absorption coefficient and Z=pc is the impedance of the medium.

D. Inverse technique The inverse technique can be used to calculate the ampli- tude and phase settings from selected control points where the desired pressure values are given. Defining Jjpck e~X Sn rmE 2; r J s rma then for M field points, expression (1) can be written in matrix notation as P=HU, (4) where /pj\ 'n \ Pi\ h"11, 2 hlN P=P2 H= hil h22 h 2, V u, U 2 utuf2 ; uN The elements of matrix H are evaluated by numerical inte- gration using cxpssion (3). Equation (4) has two important features. First, if the H matrix is calculated and saved for a desired field. then the pressure fie ! d can be evaluated using Eq. (4) instead of Eq. (1) for a given excitation source matrix U. Computation time can be saved by using this method when varying the excitation source over the same calculation volume. Second. for a desired pressure field pattern. i. e., for a given matrix P, the excitation source U can be calculated by D =Htp where H'is the pseudoinvrrse matrix of H. Usually the total number of control points are much less than the total number TABLE). Setected controt points used for inverse t :.) ku).... . < for) 6-. quare- element spherical curved phased array The control point are located at = =129 mm plane. Note the units for x and y are millimeters. - Pha. c i. 25 0. 0 O. U° Case 0. í) 1. 25 0, 0' ì.25 o. b 0. 0* 0.0--l.25O. tf. 1.2S0. 0U. 0° Case0.0 1. 25 90. 0 11-1.15 0. 0 18U. 0° oso-l25 2700 0. 0-1. 25270. 0' 3. 25 010 0. 0* Case 0. 0 3. 25 90. 01 -3. 25 0. 0 180. 01 0. 0-3. 25 270. 0' 5. 25 0. 0 0. 01 Case0.0 5. 25 90v0 IV-5. 25 O. U IF0. 0' 0. 0-5. 25 270. 0' 3. 25 U. 0 0. 0' 1.62 2. S I 60. 0° CE-i. 622. 8) t20. 0" v-3125 0. 0' 180. 0, -1.62-2. fS 1 240. 0' 1.62-2.81 300. 0' 3.250. 00. 0" 2.32. 3. 0° 0.o 3. 25 90. 0c Case-2. 3 2. 3 135. 0' vi-3. 25 0. 0 180. 01 -2. 3-2. 3225. 0" 0. 0-3. 25 270. 0o 2.3-2. 3 315. 0° of excitation sources in this case. The Hui matrix can be fol by utilizing single value decomposition. control points were selected in a plane at a desired focal position. All the points wcre evenly distributed on a circle. Since the pressure at a control point is a complex number, both the magnitude and the phase are required to perform the inverse calculations. In selecting control points in this manner, it is natural to make the magnitudes the same for all the points, and the phases either in phase or out of phase so that the phase rotates around the central axis. The latter setup gives destructive interference on the central axis thus, eliminating potential hot spots on the axis. 3 The se- lected control points used in the inverse calculations are given in Table I.

Thermat modeling An approximate temperature response to the power depo- sition was predicted by the transient bioheat transfer equa- tion. The differential equation is dT d2T d2r d2Tx p, c, d =k, TE + 8 7) b (T-Tx Q (. \ where T is the temperature at time. The location (x, @, z@ p, is the density of the tissue, c, is the specific heat of the tissue, k, is the thermal conductivity of the tissue, ìs the blood perfusion rat, c1, is this specific heat of the blood. Tn is the arterial blood temperature and Q(x, y, z) is the acous- tic power deposition rate per unit mass. The thermal response was siinulated in a homogeneous medium. A surface tem- perature of 37 °C on the cube and an initial temperature of 37 °C inside the cube were used as boundary and initial con- ditions for all of the computations.. A numerical finite differ- ence method was employed to solve Eq. (5). Previous studies have shown =hat there are severe parameters which affect the temperature elevation. l3 Temperature elevation has been shown to be almost independent of the blood perfusion rate for short ultrasound pulses. 14 For this reason, ultrasound pulse durations of 1, 5, and 10 s were used in this study. The maximum temperature reached in all simulations was kept the same (80 °C) by adjusting the input power.

F. Thermal dose calculation and necrosed tissue volume estimatlon The thermal dose calculation was based on the technique suggested by Saparcto and Dexey. l5 Using this technigue. the accumulated thermal dose A, as calculated at a reference temperature by numerical integration under different tem- perature profiles. The thermal dose, i. e, equivalent time, at the reference temperature can be evaluated by f''f. M !'' Dose(tJ) = f RT-T (t'dr > Rt 7 A r-O (6) where Te is the reference temperature. Ifi", =fheaing'+'lcooling is the final time, Ai is a small time ínterval T is the aver- age temperature during time Ar and R is a parameter given by 0. 5. if T (r) >43 QC 0. 25, other-wise The necrosed tissue volume is estimated by the isothermal dose volume surrounded for 240 min at the reference tem- perature of 43 °C. This technique has been found to be a reasonable model for predicting tissue necroses induced by a spherically curved transducer. .

A two layered medium water-tissue was assumed in the simulations. The speed of sound and the density were 1500 m/s and 998 kg/m3, respectively, for both media. The attenu- ation coefficient of the tissue was assumed to be 10 Np/m/ MHz. The thermal properties of the tissue are given in Table II.

III. RESULTS A. Comparison of experimental results with simulations It was necessary to verify the numerical model using the 16 square-element phased array with a spherical surface be- fore relying on the simulations. The experimental and simu- Ta. BLE II. Thermal properties of the'issue used in'he simulations. Parameter Value Units p, tissue density 99S kg/m3 c, zissue spec'. _ hest 3770 Jhs C k,-issue thermal conductivity 0, 5 W/m °C hwbloodperfusion nte 1,. kg/m s ch-blood specific heat 3770 J/kg'C ta-material blood temperature 37'C lated profiles of the pressure amplitude squared at the acous- tic focus are displayed in Fig. 2. All the data were normalized to 1 by dividing by the maximum pressure am- plitude squared for each curve. Figure 2 (a) shows the results for the case with uniform excitation sources. There was good agreement between the simulations and experimental results for the main beam. When the array was excited by various phase settings, the simulations reasonably predicted the side- lobe distributions found in the experiments [Figs. 2 (b)-2 (d)].

The maximum power output measured was at least 14 W for each transducer element.

B. Simulation results The phased array ultrasound transducer used in the ex- periments was simulated first. A calculation volume of 30 X3QX90 mm3 was used for this phased array. The axial dis- tance from the center of the transducer to the water-tissue interface was 70 mm. The inverse technique results are shown first. The amplitude and phase settings calculated by the inverse technique corresponding to selected control points are given in Table III (only the first four are shown).

The contour plots of power deposition calculated for these array settings are displayed in Fig. 3. For four control points, only one focus was produced, which was centered on the oye- 0. 4- 0.8 0.9 wo 'O 0. 4 (c) , oui. 0. 0 CA- 0. 4 02- Yi olo _ : :... 5-4-3-2-1 9 1 Z 3 t 5-5-4-3- ?-L 0 1 2 3 4 0 X-Distan (mm) FIG. 2. Relative pressure amplitude squared distribution as n function of lateral distance at the acoustic focus ( : =129 mm). The profile with the dotted line was measured. and the profile with the solid line was simulated, The amplitudes were ail the same w : ih phnses (a) uniform."'. (. ad (d) various. TABLEIII. Phase and amplitude seaings caiculeud with the inverx tech- nique for the 16 square-element sphecitlly curved phased array. 6n Aw . 7 64. 2 64. 2 265. 7 1. 0 2. 6 2.6 1. 0 CJse 61. 2° 58. 1'5 (° I'64. 2-2. 6 6. 2 6.2 2.6 1 64. 2 58. ì 58. 1 (64. 2 2. 6 6. 2 6.2 2.6 265. 7 64. 2 64.2 265. 7 1'° 2. 6 2.6 1. 0 119. 7* 95. 0-, 38. 0-29.7 1. 8 1 5 1. 5 1.8 Case2S. O° ! M. ! ° Kr s. o°). sf. o i. O. 5 I 185. 0° 194. 17 284. ° 308. 0° 1. 5 1, 0 1. 0 1, 5 209.7° 2 18. 0* 275. 0' 299.7° 1. 8 1. 5 1. 5 1. 8 311. 9° 212. 3 304. 3 221. 9e 1. 0 1. 0 1. 0 1. 0 Case 34.3 4. 9" 24. 9° t22. 3°. 0). 0 1.0 1.0 III 302.3° 204.9° 294.9° 2 14. 3 1. 0 1. 0 1. 0 1. 0 J1. 9'124. 3° 32. 3° 131. 9e 1. 0 t. O 1. 0 1. 0 158. 0 142. 4° 59.2 68. 0° 1. 1 1.2 1.0 1. 1 Cast. 1 49. 2 1 33. 2 43.2 52. 4 1. 0 1. 0 1. 0 1. 2 fv 232. 4-223 2 313. 2°329.2° 1. 2 1. 0 1. 0 1.0 248. 0° 239.2° 322.4'338. 0-1. 1 1.0 1. 2 1. 1 axis when the pressure at all of the control points were in phase (Figs. 3 (a) and 3 (b)]. Four focal spots were obtained if the pressure at the control points had 90.0° phase shifts from one point to another (Figs. 3 (c) and 3 (d)]. Comparing Figs.

3 (c) and 3 (d) with Figs. 3 (e) and 3 (f), the peak to peak dis- tance was increased when the control points on a 1.25-mm radius circle increased to a 3.25-mm radius circle. However, if the control points were on a 5.25-mm radius circle, the focal spots were at the same location as Figs. 3 (c) and 3 (d).

The field distributions (not shown here) were very similar to Figs. 3 (c) and 3 (d). For six control points, six focal spots were obtained at control locations with different patterns [Figs. 3 (g) and 3 (h)], and two additional focal spots were at the center. When the number of control points increased to eight, the power deposition pattern had the maximum pres- sure amplitude in front of the focal plane with strong peaks at the water-tissue interface (Figs. 3 (i) and 3 (j)]. These re- sults were used to select simplified amplitude and phase set- tings, which were then used in necrosed tissue volume simu- lations (Table IV).

The isothermal doses for tissue necrosis for five amplitude and phase settings are displayed in Fig. 4. Let us consider the ultrasound pulse duration 10-s case (solid line). For the uni- form excitation case, the focus was located at a depth of 59 mm from the interface. Based on the 240-min isothermal dose (Figs. 4 (a) and 4 (b)], the shape of the necrosed tissue volume was close to an ellipsoid. The calculated volume was about 85 mm3. measuring 3 mm laterally and 18 mm longi- tudinally. Isothermal doses are also shown in the same fig- ures for the ultrasound pulse durations of 5 and 1 s, where the input power was adjusted so that the maximum tempera- turc was kept at 80 °C. For case I of Table IV, the necrosed tissue length [Fig. 4 (c)] was 42 mm, and the width [Fig.

4 (d)] was 3.4 mm. The length was more than double and the width was slightly enlarged compared to the uniform excita- tion case. The computed necrosd tissue volume was about 339 mm3. Figures 4 (c) and 4 (f) show case II of Table IV, for yE X Cd -a zozo .. r cn 0.5 A0.5 I 1 1 7 a 9 10 11 12 13 14 15 ld-I 0& 0 0. 5 1 Z-Distance (cm) Y-Dfstance (cm) -1- !-I- d -D. 5 0-a o,0. U tn °. , o. s ° p o. 5 W t, 3 9 10 11 1Z 13 14 15 l'd-1-0. 5 0 0.5 1 Z-Distance (cm) Y-Distance (cm) "C' 0 cl o o lu 0. 5 , o G. I r 1 :, -7 B H 9 10 11 12 13 14 15 1-I O. 5 o 0. 5 1 Z-Distance (cm) Y-Distance (cm) t n _0. 5 '---0. 5 o 5 0. 5 C 0 I I C i. i 7 0 9 la 11 IS 13 14 15 ils-0. 5 0 D'i 1 Z-Distance (cm) Y-Distance (cm) - o. s X t, I. X au U p D 0 0.5 j 0.5 I a YC t >C 1 7 8 9 10 11 12 13 lut 15 16-1-0. 5 0 0.5 1 Z-Distance (cm) Y-Distance (cm) F) G. 3. Contour ptott of power deposition for calculated amplitude and phase settings. Th^ wntxrt points used to calculate amplitudes and phases from Table I were (a), (b) case 1 ; (c). (d) case II : (e). (tj case III (g), (h) case v : and (i), (j) case VL. the figures on the left side are axial plane distributions. and on the right side ue fasi plane distributions (z== 129 mm). Medical Physes, Val. R2, No. 3, March 1995 TABLE IV The simplified phase and amplitude settings for the 16 square- element spherically curved phased array used in the necrosed issue volume calculuions. A 0. 0°0.0-0 0° 0 0° ivO 1. 0 1. 0 1.0 Case 0. 0° 0. 0° 0. 0'0. 0°. 0 5. 0 1. 0 1 0. 0° 0. 0° 0. 0" 0. 0= 1. 0 5. 0 5. 0. 0 0.0° 0. 01 0.0 0. 0° I. I. 0 1. 0 I. 0 90.0°90.0'0. 0'0. 0'ì. O 1. 0 1. 0 i. O Case 90 0'90. 0'0. 0'0. 0° 1. 0 1. 0 1. 0 1. 0 II ISO. 0° 180. 0° 270.0' 270. 0° 1.0 1. 0 1. 0 1. 0 180. 0° lR0. 0' 270. 0° Z70. 0' I. 0 1. 0 1. 0 1. 0 270.0° I 50. 0° 270. 0° 180. 0 I. 0 1. 0 1. 0 1. 0 Case 0.0° 90.0'0. 0'90. 0° 1. 0 1. 0 1. 0 1.0 III 270.0° 180. 0° 270.0° I 80. 0° I. 0 1. 0 1. 0 1.0 0. 0° 90. 0- 0. 0° 90. 0° I. 0 !. 0 l. 0 I, 270.0° 240. 0° 210. 0' 180-01 1. 0 1. 0 1. 0 1. 0 Case 300. 0 90.0° 0.0 1 50. 0 1. O I. 0 1. 0 1.0 IV 330.0° 180. 0° : 70. 0° 130. 0 1. 0 1. 0 I. 0 1. 0 360. 01 30.0° 60.0 90. 0 1. 0 1. 0 1. 0 1.0 which the necrosed tissue length and width were 20.8 and 5.1 mm, respectively. The length was slightly longer and the width was almost double compared with the uniform excita- tion case. Notice that this case is equivalent to the situation in which the phased array had only four elements with sides of 39.4 mm. The calculated necrosed tissue volume was about 377 mm3. Figures 4 (g) and 4 (h) indicate that there were four focal points in the power deposition for case III of Table IV. The shortest peak to peak distance was about 4x. where \ is the wavelength. The whole volume was the sum- mation of the four individual small necrosed tissue volumes which were produced by the four focal points. Each small volume was about the same size as the volume in the uni- form excitation case for the 1-and 5-s sonications. For the 10-s sonication a united volume was created with the total volume of 810 mm3. For the amplitude and phase setting of case IV in Table IV, the power deposition (not shown here) indicated that there were four strong focal points (depth 54 mm) surrounded by four small focal points. The shortest dis- tance between the stron peaks waS about 2\. Simultaneous focusing at these points was performed to enlarge the heated volume compared to the uniform excitation case. The calcu- lated isothermal dose [Figs. 4 (i) and 4 (i)] from the tempera- ture distribution had a maximum length of 38.5 mm and a maximum width of 7.2 mm. and the necrosed tissue volume was close to 1.4 cm3.

To illustrate the effect of frequency on necrosed tissue volume production, the isothermal doses for case IV of Table IV with an ultrasound pulse duration 10 s are shown in Figs.

5 (a) and 5 (b). The calculated volume was 60X60X90 mm3 for. 0. 5 MHz, 40x40x90 mm3 for 1.0 MHz. and 30X30x90 mm3 for 1.4 and 2. 0 MHz. The distance from the transducer to the interface was kept the same (70 mm), while the fre- quency was varied. The ratio of the necrosed tissue length to width was almost independent of frequency The size in- creased as the fregue,. y decreased. Tne shapes were similar for frequencies of 1 to 2 MHz.

To understand the effect of radius of curvature on the necrosed tissue volume, the isothermal doses for case IV of Table IV, with an ultrasound pulse'duration of 10 s and op- erating frequency of 1. 4 MHz are displayed in Figs. 5 (c) and 5 (d). The distance from the transducer to the interface was varied according to the radius of curvature to maintain a constant focal depth. The necrosed tissue volume increased rapidly along the lopgitudinal direction toward the interface as the radius of curvature increased. However, the diameter of the necrosed tissue voiume increased only slightly in the focal plane.

To show the capability of the phased a. ray to move the focus, contour plots of the power deposition for the maxi- mum displacement are displayed in Fig. 6. The simulation model was the same as the one used to generate Fig. 3. The phase distributions were obtained based on direct calcula- tions, i. e., phase #"= =2 7rd,/X, it = 1, 2..... N, where d, is the distance from the center of the element to a dcsired focus.

Figure 6 (a) shows the results for the case With uniform am- plitude and phase setting. The focus could be moved 7 mm closer to the interface [Fig. 6 (b)], or 7 mm deeper [Fig. 6 (c)] compared with Fig. 6 (a). Figure 6 (d) shows the phased array focus shifted 1.5 mm off the central axis. When larger dis- placements were attempted, the phase increment between ad- jacent elements exceeded Tr/2. Distributions generated by those phases are no longer single, strongly focused ultra- sound fields. Therefore these were the maximum displace- ments achievable with this array in the sense of keeping the fields in the region of focus similar to those for the uniform excitation case.

Finally, Fig. 7 shows the input power requirements for the uniform excitation and four amplitude and phase settings given in Table IV. For ultrasound pulse durations of 5 or 10 s, the power ranged from 30 to 250 W. For a 1-s pulse, the input power could be as high as 900 W, depending on the amplitude and phase settings.

IV. DISCUSSION The experimental and simulation results showed that a 16-element phased array can offer significant control over the size and shape of the necrosed tissue volume during ul- trasound surgery. The experiments showed that such an array can be constructed and it can deliver enough power for sur- gical purposes. The simulated and experimental ultrasound field distributions agreed reasonably well. The differences may be due to uneven element size and power output in the phased array as well as measurement errors. Since the peak to peak distance was only a few millimeters, the ultrasound detector may contribute some measurement errors. The simu- lation model accurately predicted the locations of sidelobes and main beams except that it over predicted the magnitude of the sidelobes. When adjacent elements of a phased array are very close to each other, the mutual coupling between the elements would have an effect on the ultrasound field. The difference between the sidelobes in the experiments and the simulations may be due to the lack of such crosstalk in the calculations The auove results proved that the large element spheri- cally curved phased array can enlarge the necrosed tissue , _r 5_ _, rs-O. S- ' Q s . w 0 ; v c : x | 0. 5-x 0. 5, A 10 11 12 13 14 15-0_5 p. 0 0. 5 ZDistance (cm) Y-Distnce (cm) 5--1), 05 t.' !. 0. 0- 010 .. 0.5 ' 0.5 A 10 11 12 13 tt 15-0. 5 0. 0 0. 5 Z-Distance (cm) Y-Distance (cr) S 1 0. 5- 0. 5 (e) o. o ; o. o.. 0. 0- 0. 5 0. 5 A 10 11 12 13 14 15-0. 5 0.0 O. 5 Z-Distance(cm) Y-Distance (cm) ......... ............... -.,... 0. 5-oPs- 0. 5, 0. 9 10 11 1Z 13 H 15-0. 5 0. 0. 5 Z-Distance (cm) Y-Distance (cm) -o. s 0. 5 _s D. 5 B-n (|) iEb o. uXl ;, ., : . A - 8 10 11 12 13 14 ils-0. 5 0. 0 0. 5 Z-Distance(cr 7r-Distamce (cm Fia. 4. lsothermal doses for the uniform excitation case (a). (b) and the amplitude and phase settings in Table IV ; (c), (d) case 1 : (e). If) case Il : (g). (h) case IU : and (i). (j) case IV. The figures on the left side are axial plane distributions. and on the right side are focal plane distributions [(b).. = 129 mm. (d) 2. 128 mm. (f) z-179 mm. (h) : = 129 mm, and (j) : = 124 mm). The ultrasound pulse durations used in the thermal dose caiculations were 10 s (solid line). 5 s (dashed line), and I s (doned line). -2-2 .. .. 0. 5 MHt..... 0. 5 Mliz -i'i----1. 0 MHZ (a) .---l. OtMt. ft) -'-',..-,-.-.-1-4 MHt,-.-----1. 4HHt -i z. o _A z. o nu= .. ..................... ..............-0. 5- o h) §, i < OS 0 1 1 .......... 2 2 7 8 8 10 11 12 13 It t9 10-Z-1. 5-1-0. SO Ml 1J ! Z Z-Distance (cm) Y-Distance (cm) -z-z rediua af curvacure radlus oE cnrveure -l. 5 ( )..... 1o em.... d-20 cm -16 em-I. 5 ( _ _ 16 cm .., _. _.. 13 cm _ _. _. _ 13 cm B em V B cm y-0. 5 '', _. _. ___. _. _ _.. _ : __ ; -'-0. ;.. 0- ............ . 1. 5 2 2 « s aS m o t z 3 4 5 8 7 8 9 2-1ß-1-OS tt 0. 5 l 13 2 Depth (cm)-Y-Distanre (cm) FXG. 5. The isothermal dose for cue IV of Table IV with various frequencies (a). (b). and with various radii of curvature (c). (d). The ultrasound pulse duruion used in the thermal dose calculations was 10 s. The distance from the transducer to the interface was 130. 100, 78. and 32 mm for radii of curvature of 200, 160. 130, and SO mm, respectively. (a), (c) is axial plane distribution. and (b), (d) is the focal plane distribution. volume. The phased array can also enlarge the necrosed tis- sue volume in only one direction at a time. if desired. It is important to be able to control the focal spot size so that a large tumor could be treated in a reasonable time. The con- struction of the whole system was relatively simple due to the small number of elements. The 16-element phased array can also shift the focus off the central axis or move the focus along the central axis. However the distance is limited to 1. 5 mm laterally and 14 mm in the axial direction. In mov- ing the focus along the central axis, the array is similar to a concentric-ring array with two rings. Theoretically, the maxi- mum phase increment between adjacent elements is s7.

Therefore, the maximum possible phase difference between the smallest and largesr phases is w when moving the focus <BR> <BR> along the central axis. From geometric considerations. this<BR> phase difference produces displacements along the central axis of up to 23 mm (10 mm closer, 13 mm deeper). In shifting the focus sideways, it is similar to a cylindrical- section array with four elements. The maximum possible phase difference between the smallest and largest phases is 3w for shifting, the focus sideways. Geometrically, this phase difference shifts the focus'3. 4 mm laterally. However, the simulations showed that the phase increment between the adjacent elements shots'4 be íess th. n xT12 to generate a single strongly focused ultrasound field.

The 16-element phased array can generate four focal points with a peak to peak distance as short as two wave- lengths. The maximum distance between the closest peaks is limited to about four wavelengths. When the four control points were on a circle of radius 5. 25 mm, the phase incre- ment between adjacent elements exceeded 7r for this array.

Wherefore, it is physically impossible to use the phase and amplitude setting obtained by inverse techniques to produce the four focal spots at the control points. Although Eq. (4) represents an underdetermind system, it produced a solution at the control points. When multiple foci are separated by distances larger than 4.6 mm. the necrosed tissue volume becomes a few individual smaller volumes, which are not united for short ultrasound pulse durations.

By decreasing the frequency. the necrosed tissue volume can be enlarged because the focal spot increases due to the increased wavelength. But the ratio of the necrosed tissue length to the width was kept almost the same. As the radius of curvature is increased, the necrosed tissue volume can also be enlarged. The necrosed tissue volume is increased mainly in the axial direction. This agrees with previous experience using single element spherically curved transducers.'3 Phased arrays require more input power than similar .'. ingle focused transducers to reacn the same temperature level for the same ultrasonic pulse duration due to increased 900 o. e (a) gpp''10 3 7 g 1 S ; 0-700 5S _1 600 ;'' : o. s (b) _ ;, : o. v , j i ; . 1 200 1 zD 500, ¢ £ L =< ffi 0 Gj o !o case 1 case 2 case 3 case 4 cese 5 ' o FiG. 7. The inpw power requiremem to reach the same temperature le%, Ci at the end of ultrasound pulses for sajous cases. Cnse 1 i5 for the uniform excitation case. case 2-5 are corresponding to the amplitude and phase 0. 5 (d) settings of case l^lV in Table IV. 0 o g -0. 51 to compensate for the effect of tissue nonuniformities which may diston the focal pattern." 9 10 11 12 13 14 15 16 Z-Distance (cm) Firi. 6. Contour plots of power deposition for various amplitude and phase seetungs. (a) is the uniform excitation case. The axial distance from the transducer to the focus was (aj 129 mm. (b) 122 mm. (c) 136 mm. and idl 129 29 mm. shifted). S mm focal spot size. The test array measurements showed that therequired power levels can be generated in practice at least <BR> <BR> and 10-s exposures and thus. the proposed technique is<BR> tJíble.

In order to obtain the desired field pattern, several field control points are necessary to perform the inverse calcula- tions. However, the number of utilizable field control points is limited by the number of phased array elements. Hence the number of field patterns that produce significantly different shapes or sizes of the measured volume is limited. Although only few amplitude and phase settings were presented in this study, the results provided information which could aid in planning ultrasonic surgery using a phased array system with a small number of elements. These results have not been optimized; nevertheless they illustrate the feasibility and range of focal size and shape. obtainable with a 16-element array. The calculations and experiments can be used to obtain a set of different focal spots for a given array. This limited number of focal spots can then be utilized to optimally cover the target volume in minimum time. The minimization of the duration of the treatment is an important factor for control- ling the cost of the procedure, especially when MRI is used to guide and monitor the treatment. l6 If more control over the field pattern is required then an array with a larger num- ber of elements is required. Such an array could also be used ACKNOWLEDGMENT This study was supported by NCI Grant No. CA 46627. ''Department of Eleetrical and Computer Engineering. University of Ari- zona. Tucsun. AZ 8572). 'K. Hynynen."The threshold for thermally significant cavitation in dog's thigh muscle in vo.''Ultrssound Med. Biol. 17, 157-169 (1991). J. R Do-Huu and P. Hartemanm Annular anay wrnsducer for deep aeouslic hypenhennia."Uhrasonics Symp. Proc. IEEE-SI CH 1689-9. 705-710(í981). K. B. Ocheltree, P. 1. Benktser, L. A. Frizzell. and C. A. Cain."An ultrasonic phased array applicator for hypenhermia."IEEE Trans. Sonics Ultrason.. SU-31. 526-531 (1984). .'C. A. Cain and S. Umemura. *Concentncwring and sector-vonex phased array applicators for uhrasound byperthermie."IEEE Trans. Micowave TheoryTeeh.. MTT-3. S2-M) 09S6). f P. J. Benkeser, L. A. Frizzell, K. B. Ocheltree. and C. A. Cain, *'A tapered phased array ulurasound transducer for hyperthermia meatment."IEEE Thns. Uluason. Fenroclcc. Frcg. Contr. UFFC 34. 446-4'i3 (1987), 'E. S. Ebbini. S. Umemura. M. Ibbiñi. and C. A. Caia."A cylindrical- section ultrasound phased-array applicator for hypmhermia cancer therapy,"IEEE Trans. Ultrason. Ferroeiectr. Freq. Contr. 35. 561-572 (l988). 'E. Ebbini and C. A. Cain."A spherical-section ultrasound phased array applicator for deep locali2ed hypertberrnia,"iEEE Trans. Biomed. Eng. BME-38. 634-i3 (19911. E. Ebbini and C. A. Cain." : dullipte-focus ultrasound phased-arYay pat- tern synthesis : Optimal driving-signal diuributions for hypenhermia." IEEE Trans. Ultrason. Ferroelectr. Freq. Contr. 36.540-548 (í9sg). 9iM. Buchanan and K. Hynynen."Design and experimental evaluation of intracavitary ultrasound phased array systems for hypenhertnia."IEEE Trans. Biomed. Eng. ONIE-41. 1) 79-1187 (1994). '°H. T. O'Neil,"Theory of focusing radiators,"J. Acoust. Soc. Am. 21. 516-526 (1949). X. Fan and K. Hynynen."The effect of wave reneetion and refraction at soft tissue interfaces during ultrasound hyperthermiia reatments."J. Acoust. Soc. Am-91. 1727-1736 (1992), -l2X. Fan and K. Hynynen."The effects uf curved ussue layen on the 306 X. Fan and K. Hynynon : Control of neerosod tiseue volume during ultrasound suryery 308 power deposirion pattern. of theta, oeutic ultrasounu beams,'-Med. Phys. 21. 25-34 (1994), "C. Damianou and K. Hynynen :"The effect of various physical, param- eters on the size and shape of necrosed tissue Volume turing ultrasound Surgery,'1,Acoust. Soc znn. 95, 164) t9 (1994), ßB. E. Billard. K. Hynynen. and R. B. Roamcr,"Fffects of'physical pa- rameters on high temperature ultrasound hypenhennia."Uluasound Med. Biol. 16, Zi9^420 (1990). 5s. A : Sap reto and W. C DeweyMB Xhermal dose determinaion in cancer therapy."In (. J. Radial. Oncol. Biol.'Phyi.'-iO, 787-SM (1994). '6K. Hynynen, A., Darka2q, nli. E.. Unger, and J. Schenck."MRI-guided noninvasive uhnsound stfrgery."Med. Phys. 20, 107-115 (1993).




 
Previous Patent: SURFACE OPENING ADHESIVE SEALER

Next Patent: SUTURING SYSTEM